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ABSTRACT 
The biochemical and physiological functions of a large proportion of the approximately 
27,000 protein-encoding genes in the Arabidopsis genome is experimentally undetermined 
using sequence homology techniques alone. This thesis presents a set of bioinformatics 
resources including a software platform for data visualization and data analysis that address the 
key issues in incorporating the metabolomics data for functional genomics studies. 
Multiple mass spectrometry based metabolomics platforms are combined together to get 
better coverage of the metabolome. Different strategies for integrating the metabolomics 
abundance data from multiple platforms are compared to find the ideal method for biomarker 
discovery. A new method of putatively identifying unknown metabolites by first order partial 
correlation networks is proposed that uses the existing data to incorporate structurally unknown 
metabolites. A comprehensive study of 70 single gene knock mutants vs. wild type samples is 
performed using Random Forest machine learning algorithm and a biomarker database for each 
of the 70 mutations is built with the key metabolites including the putative identifications of 
unknown metabolites.  
A proof-of-concept analysis on the  oxoprolinase (oxp1) and gamma-glutamyl 
transpeptidase (ggt1 and ggt2) single gene knock-out mutants in the glutathione degradation 
(GSH) pathway of the Arabidopsis confirms the known biology that OXP1 is responsible for 
conversion of 5-oxoproline (5-OP) to glutamic acid. In addition, ggt1/ggt2 analysis supports the 
hypothesis that the GGT genes may not be major contributors for the 5-OP production. Also, the 
lack of biochemical changes in ggt2 mutation supports the previous studies of its low level 
expression in leaf tissues.  
The metabolomics database, the biomarker database and the data mining tools are 
implemented in a web based software suite at www.plantmetabolomics.org. 
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CHAPTER 1. INTRODUCTION 
Metabolomics is an important functional genomics tool and can be used in finding the functions 
of genes where sequence genomics techniques alone are not adequate. However, the 
bioinformatics resources and methods for the metabolomics are still very new and under 
developed. One of the biggest challenges in metabolomics is to integrate multiple platforms as 
no single analytical technique or platform can cover the whole metabolome of an organism and 
to understand the role of structurally unknown metabolites which constitute a major part of the 
detected metabolites in any large scale metabolomics study.  
This thesis communicates my contribution to the field of bioinformatics in metabolomics area. 
This includes database and tool development to integrate multiple metabolomics platforms and 
development of new techniques for the analysis of the metabolomics data. The main chapters of 
this thesis are published, or to be submitted manuscripts in peer reviewed journals in plant 
science and bioinformatics area and discuss my solutions for the above stated problems in 
metabolomics. The thesis is organized as follows – 
Thesis Organization  
• Chapter 1: Introduction and the contribution of thesis in Metabolomics area. 
• Chapter 2: General Introduction: Discusses the general background of the available 
metabolomics technologies and bioinformatics resources.  
• Chapter 3: Plantmetabolomics.org A database for plant metabolomics 
experiments: Discusses a web based database, PM (www.plantmetabolomics.org) that 
combines 11 different analytical platforms to detect ~1400 metabolites in 140 single 
gene knock out mutants of Arabidopsis.  A researcher can use this database and 
visualization tools to compare biochemical changes due to a mutation to form hypothesis 
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about the function of a gene of interest. This chapter was published in Plant Physiology 
in 2010. 
• Chapter 4:  Plantmetabolomics.org: Mass Spectrometry based Arabidopsis 
metabolomics database and tools- Update: Discusses new multivariate and machine 
learning data analysis and data visualization tools that were incorporated in PM 
database in 2011 along with new morphological data.  This database along with the new 
data mining and visualization tools provides a hypothesis building platform for the 
researchers that are interested in functions of any of the genes contained in the 
database. This work has been published in Nucleic Acid Research 2012 database issue. 
• Chapter 5: Data analysis pipeline in functional genomics using metabolomics and 
machine learning: Discusses the methods and data analysis pipeline to analyze and 
integrate metabolomics data from multiple platforms for biomarker discovery. These 
methods are tested on 3 genes of an Arabidopsis pathway to confirm the known biology 
and provide new knowledge. This chapter is based on a manuscript that is to be 
submitted to Plant Physiology in 2011. 
• Chapter 6: Partial correlation networks to putatively identify unknown metabolites 
in non-targeted metabolomics: Discusses a comprehensive study on 70 mutation lines 
of Arabidopsis using machine learning and gas chromatography mass spectrometry 
based metabolomics. A biomarker database is created for the key metabolites for the 
classification of mutant vs.  wild type samples for all of these mutation lines.  First order 
partial correlation networks built across the mutation are used in putatively identifying the 
potential biomarkers of unknown structures from a machine learning method. This 
provides a cost effective way of incorporating the unknown metabolites to gain biological 
insight. This chapter is based on a manuscript that is to be submitted to Plant Methods in 
2011. 
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• Chapter 7: Conclusions: Conclusions and significance of this work.  
  
4 
 
CHAPTER 2. METABOLOMICS: GENERAL BACKGROUND 
What is Metabolomics? 
Metabolic analysis is the study of small molecules (molecular weight <1,000 Da) in a biological 
system (Fiehn O. et al. 2000; Hall R. et al. 2002). The biochemical state of an organism is the 
result of interaction between its genotype (G), its environmental (E), and its homeostasis 
mechanisms. Living cells respond to environment or genetic perturbation and this response can 
be measured by quantifying the change in concentration of metabolites. Metabolic information 
reflects the response of a plant cell to its environment or genetic perturbation more accurately 
than the sequence or the gene expression analysis as it is the end product of a gene’s 
expression .Metabolomics can be a useful tool in assessing the plant’s physiology, growth 
characteristics, and stress response (Sumner L. et al. 2003).  
Some Examples of Usage of Metabolomics 
Metabolomics is increasingly used in determining and improving quality traits such as the color, 
taste and flavor of the plants because these traits are related to metabolic composition. For 
example, metabolomics analysis was done in tomato using domesticated and undomesticated 
species to discover the primary and secondary metabolites that contribute to flavor and color 
(Schauer N. et al. 2005). A combination of genomic analysis with metabolomic profiling 
identified novel genes involved in the fragrance production in rose petals (Guterman I.et al. 
2002). Metabolic composition analysis was performed on the samples from genetically modified 
and conventional potato tubers to find out if GM potatoes had any undesired or potentially 
harmful metabolites apart from the targeted changes (Catchpole G. et al. 2005).  Metabolic 
profiling has also been  used to explore the degradation process of linoleic acid in stored apples 
(Beuerle T. et al. 1999).  
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Metabolomics as a Functional Genomics Tool 
There are about 27,000 protein-encoding genes in the Arabidopsis genome whose functions are 
experimentally undetermined.  The functions of these genes are either completely undermined 
using sequence homology or can only be classified in the broad functional classes. The first 
category of unknown genes consists of 9000 genes that share no sequence homology of any 
genes in the sequence database or share sequence homology to genes of unknown functions. 
The second category consists of approximately 15000 genes. This thesis is part of a multi-
disciplinary experimental system that has been developed to generate and evaluate 
metabolomics data as a tool for deciphering gene function in Arabidopsis by knocking down a 
single gene and comparing its metabolomics concentration data with the wild type samples 
while keeping the environment stable. Since the metabolome reflects the final outcome of a 
genes expression at the molecular level, the comparison of single gene knock outs with the wild 
type samples may give clues to the functions of a gene. This thesis focuses on the 
bioinformatics solutions and computational infrastructure development for the same. The 
following paragraphs introduce the existing technologies and practices along with the 
challenges in the metabolomics area. The later chapters discuss our proposed solutions to 
some of these challenges. 
Types of Metabolic Analyses 
Metabolomic analyses can be divided into targeted and non-targeted analyses. Targeted 
analysis aims at a selected group of metabolites or pathways and provides precise 
quantification of those metabolites in a sample. This method requires that the structure of the 
targeted metabolites is known and that the metabolites are available in purified form before the 
analysis. Targeted methods cannot detect any novel metabolites in a sample (Aharoni A. et al. 
2002).  
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Non-targeted analyses can be further divided into finger printing and metabolic profiling. 
Fingerprinting is a high throughput, global analysis of samples which provides a global snapshot 
without precisely quantifying or identifying all the metabolites in the sample. It is mainly used to 
discriminate between two samples under different biological conditions. Metabolic profiling 
analysis is an unbiased comprehensive analysis of all the metabolites of a biological system. 
The biological system is perturbed and abundances of all metabolites are compared between 
two types of samples to determine the effect of perturbation. This is more difficult than targeted 
analysis as the number and classes of the metabolites affected by the perturbation is usually not 
known and the results are sensitive to  bias and selective reporting (Fiehn O. 2002). A two 
tiered approach is also employed in some recent studies where an initial assessment is first 
performed with fingerprinting and then a more targeted approach is applied with higher 
resolution methods. For example, the two tiered approach was applied in comparison study of 
two closely related potato crops (Catchpole G.et al. 2005). 
The Metabolomics Workflow 
 A typical plant metabolomics experiment consists of the following sequential steps: 
experimental design, plant cultivation, extraction, separation and detection, and finally data 
analysis. Figure 2-1 illustrates this flow and shows how data must be collected in a searchable 
database for ongoing analysis and annotation. 
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Figure 2-1 Block Diagram of main steps of a typical plant metabolomics workflow 
Experiment Design  
The primary aim of most metabolomics study is to find the difference between the samples that 
are subjected to genetic or environmental stimuli. Metabolomic experiments tend to be noisy 
and interpretation of experimental results can be faulty due to bias, inadequate sample size, 
over fitting and excessive false discovery rate due to multiple hypotheses testing. Powerful 
multivariate analysis techniques that are commonly used in the high dimensional metabolomics 
data require adequate number of sample replicates. It is also very important to store the 
metadata of the experiment design in a structured setup so the experiment results can be 
tracked and verified. For mass spectrometry based experiments, SetupX and Binbase provide a 
framework that combines data and biological metadata for steering laboratory work flows and 
employs automated metabolite annotation (Scholz M. et al. 2007).  
Database 
Design Experiment 
Cultivate Plants 
Extraction 
Separation and Detection 
Data Analysis 
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Plant Cultivation 
 To avoid variations among samples in a plant metabolomics experiment, large volume growth 
chambers are normally suggested to minimize the variance due to soil, temperature and 
humidity. In case of small volume growth chambers rotation of the pots is suggested and in 
some recent studies soil less ceramic culture system is also used to maintain the exact supply 
of plant nutrition and water (Fukusaki E. et al. 2003).   
Extraction 
First, quenching is performed to freeze the status of the metabolome at a given time and then 
metabolites are extracted from a biological sample. Different extraction procedures are applied 
to different classes of metabolites depending on their solubility, stability, interferences in the 
extraction solvents. A good extraction procedure stabilizes a large number of metabolites 
without any degradation or modification of the targeted metabolites. There is always a tradeoff 
between comprehensiveness and metabolite stability because extraction conditions that are 
ideal for one class of metabolites may degrade other classes of metabolites (Maharjan R. et al. 
2003). 
Separation and Detection  
In a typical metabolomic profiling experiment, multiple biological samples from different stimulus 
conditions, various time points, and/or genetically distinct cultivars are analyzed to discover 
biomarkers and their associated biochemical pathways. There are several analytical 
technologies that are used for separation and detection of individual metabolites from a complex 
mixture. Each technology has its own advantages and disadvantages therefore a combination of 
these technologies is commonly applied. Some widely-used analytical methods are described 
below: 
Nuclear Magnetic Resonance (NMR) 
NMR is a non-destructive analytical method and can determine the molecular structure along 
with the quantity of metabolites. NMR has several advantages in comparison with other 
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analytical technologies for high-throughput metabolite analyses. As a non-destructive method, 
NMR does not require metabolite derivitization and ionization (Hagel J. et al. 2008). The non-
destructive method can be highly automated to achieve high sample throughput.  NMR spectra 
can be obtained in vivo from cultured cells and tissues (Ratcliffe R. et al. 1994; Ratcliffe R. et al. 
2001). However, NMR suffers from relatively low sensitivity (Katja D. 2007; Pan Z. et al. 2007), 
than chromatography-coupled mass spectrometry (Sumner L. et al. 2003). 
Mass Spectrometry (MS)  
MS is often used as a hyphenated technique where the metabolite mixture is first separated 
using gas chromatography (GC), liquid chromatography (LC), or capillary electrophoresis (CE) 
and then analyzed by MS, which produces mass spectrum which is an intensity vs. m/z (mass-
to-charge ratio) plot representing a chemical analysis. The unknown compounds are identified 
by comparing its experimental mass spectrum against a library of mass spectra. Manual 
interpretation or software assisted interpretation of mass spectra are performed if the 
experimental mass spectrum does not match any spectrum in the database. Recent 
developments in the instruments have greatly increased the number of metabolites that can be 
accurately identified and quantified by chromatography-coupled MS. More detailed discussion of 
the MS technology is provided in the later part of this section. 
Separation in MS 
• Gas chromatography – mass spectrometry (GC-MS): GC-MS involves the separation 
of volatile, thermally stable analytes by GC and subsequent detection by electron 
ionization (EI) MS (Hagel J. et al. 2008). It is most suitable for analyzing amino acids, 
sugars, sugar alcohols, aromatic amines and fatty acids (Roessner U. et al. 2000). GC-
MS offers high chromatographic reproducibility and resolution and is lower in cost than 
the LC-MS or CE-MS that are described below (Kopka J. 2006; Katja D. 2007) , but 
some large and polar metabolites cannot be analyzed by GC. There are currently many 
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commercial and public mass spectral reference libraries for GC–MS including the NIST 
database (http://www.nist.gov/srd/nist1.htm). GC-MS technology requires that samples 
be either volatile or  chemically derivatized (Sumner L.et al. 2003). Recent applications 
of GC-MS include mutant classification (Messerli G. et al. 2007), functional genomics 
(Schauer N. et al. 2006), and the integration of metabolite and transcript datasets 
(Carrari F. et al. 2006; Baxter C. et al. 2007; Fatma K. et al. 2007). 
• Liquid chromatography – mass spectrometry (LC-MS): LC provides covers a wider 
range of metabolites than GC. Non-volatile metabolites can also be analyzed because it 
does not require derivitization.  However, it is difficult to compare LC-MS chromatograms 
between different laboratories because of the variety of LC-MS instrumentations (Moco 
S. et al. 2006). Mass spectral reference libraries for LC-MS (e.g. METLIN database 
(Smith C. et al. 2005) are also much fewer than the GC-MS libraries. Some examples of 
LC-MS include identifying secondary metabolites in roots and leaves of Arabidopsis (von 
Roepenack-Lahaye E.  et al. 2004), and to compare tubers of potato of different genetic 
origin and developmental stages (Vorst O.et al. 2005).  
• Capillary electrophoresis – mass spectrometry (CE-MS): CE-MS is useful in 
detecting charged metabolites because  it separates compounds according to their 
mass-to-charge ratios  (Hagel J. et al. 2008). CE-MS has been used to study amino 
acids, carbohydrates, vitamins, organic acids and inorganic ions (Soga T. et al. 2001).  
Soga T. et al. (2003) used CE-MS to analyze anionic metabolites, cationic metabolites, 
and nucleotides and Coenzyme A compounds, achieving a comprehensive coverage of 
the metabolome (Soga T. et al. 2003). CE-MS is also combined with CE diode array 
detection to simultaneously determine the main metabolites in rice leaves (Shigeru S. 
2004). 
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Detection 
     The metabolite detection process involves the following steps. 
• Noise reduction:  Baseline correction and noise reduction are performed on the raw 
data as a first step.  
• Peak identification and quantification:  After the initial noise reduction, peak detection 
and deconvolution of overlapped peaks are performed. National Institute of Standards 
and Technology (NIST ) provides the free software called AMDIS (Automatic Mass 
Spectral Deconvolution and identification System) which extracts individual component 
spectra  from  GC/MS data and compares all separated components against a library of 
compounds (Stein S.1999). WILEY (Palisade Cooperation, Newfield, NY) also provides 
mass spectrum library of compounds for identifications. Sample preparation and detector 
sensitivity cause the signal intensity to change over time, therefore internal standards 
are added to the sample. The variation in intensity of these internal standards is used to 
normalize between samples (Jonsson P. et al. 2005).  
• Structure elucidation: Some of the well-known small molecule structure databases 
which contain the physical-chemical properties of  standard compounds are LIGAND 
database (Goto S.et al. 2002) and the NCI database (Korcok M. 1985). The Golm 
Metabolome Database contains GC libraries for plant metabolites (Kopka J. et al. 2005).  
• Naming conventions for unknown compounds: Unbiased analysis of the 
metabolome discovers many new metabolites and it is very important to name these 
new metabolites in a consistent way so the results from various experiments can be 
compared against each other. The novel and unknown compounds from a metabolomics 
experiment that do not match any known compounds from the above described libraries 
are given a unique name which combines the information about retention index, polarity 
among other important features of the mass spectra for that compound (Bino R. et al. 
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2004). For example BJN-GCMS-CW-20.201 is the unique identifier for an unknown 
metabolite from Dr. Basil J. Nikolau’s (BJN) lab using Gas Chromatography Mass 
Spectrometry (GCMS) for Cuticle Wax (CW) extraction and with the retention index of 
20.201.  
Data Storage 
The outcome of a metabolomics experiment is a matrix that contains the metabolite abundance 
data along with the annotations for the metadata of the experiment. It is very important to 
capture the experimental conditions along with the experiment design information to be able to 
generate reproducible results. This can be enabled by a good lab information management 
system (LIMS) for data capture and submission. For examples : SetupX and Binbase provide a 
framework that combines mass spectrometry data and biological metadata for steering 
laboratory work flows and employs automated metabolite annotation (Scholz M. et al.2007). 
Standards for the annotation of metabolomics experiments are still under active development 
and are based on the recommendations of the Metabolomics Standards Initiative 
(MSI)(Sansone S. et al. 2007). MIAMET (Minimum Information About a METabolomics 
experiment) defines necessary information that should accompany the experimental data to 
make it useful and understandable (Bino R. et al. 2004). MIAMET suggests that each 
metabolomics experiment should contain information about its design, samples, sample 
preparation, metabolite extraction and derivation, metabolic profiling design, metabolite 
measurement and specifications. ArMet is a framework and database model for the description 
of plant metabolomics experiments. It captures the entire timeline of a plant metabolomics 
experiments (Jenkins H. et al. 2004). 
Examples of plant metabolomics databases: 
• The Golm metabolome database (GMD) provides metabolite GC-MS libraries and one 
set of metabolite profiling experiments for plants (Kopka J. et al. 2005). 
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• Metabolome Tomato Database (MoTo DB) is an LC-MS based metabolomics of tomato 
fruit (Solanum lycopersicum) (Moco S.et al. 2006). 
• Madison Metabolomics Consortium Data base (MMCD) - NMR data base (Cui Q. et al. 
2008). 
• Platform for Riken Metabolomic (PRIME) is database of multi-dimensional NMR 
spectroscopy, GC/MS, LC/MS, and CE/MS based metabolomics and provides tools for 
integration with other omics data (Akiyama K. et al. 2008). 
• Human metabolome database (HMDB) provides the most comprehensive database of 
human metabolites (Wishart D. et al. 2007). METLIN compiles an extensive list of known 
metabolites and provides their MS/MS spectra with links to KEGG database (Smith C. et 
al. 2005).  
Data analysis and Biological Interpretation 
The outcome of a metabolomics experiment is a data matrix that contains the metabolite 
abundance information for all the metabolites that were detected for a sample under a specific 
condition. The number of variables (metabolites) is usually much larger than the number of 
samples as shown in Table 2-1  
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Table 2-1 Example of Metabolomics Data 
 Methionine Serine Glu Metabolite 
10 
Metabolite 
11 
Metabolite 
12 
Metabolite 
13 
MT1 1.0 23.3 2000    .. 
MT2 1.5 23 N     .. 
MT3 1.3 22 2300    .. 
WT1 100.2 22 2500    .. 
WT2 111.1 22 2500    .. 
WT3 100 22.1 2200    .. 
 
Table 2-1 Example of Metabolomics Data A sample data matrix in a metabolomics 
experiment. There are 3 replicates of the mutant samples which are compared against the 3 
replicates of wild type samples to assess the effect of mutation. The abundance levels of many 
metabolites are tested. Sometimes the abundance is below the detection limit of measuring 
instrument which is shown as an “N” in the above example. A typical metabolomics data 
contains many features (metabolites) and very few samples. Some of the metabolites have 
known structures but many have unknown structures and are given a unique identifier. 
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A typical data analysis process is described below: 
Data Preprocessing:  
Data preprocessing is performed to improve the overall data quality and prepares the data 
for statistical analysis with improved accuracy. Some key preprocessing steps are described 
below 
• Outlier detection: The outliers are data points which differ from the most of the other 
data points. This difference can be due to the biological reasons which can lead to 
discovery of novel pathways (Tjalsma H. 2007).  The outliers which may be due to non-
biological reasons are then removed before any further statistical analysis. In general, 
the outliers are the values which are more than 3 standard deviations away from the 
sample mean. Statistical methods such as principle components analysis (PCA) and 
independent component analysis (ICA) which are discussed later can be used in outlier 
detection. No computational method can determine if the outlier is due to biological or 
non-biological reasons, therefore expert knowledge of the biology is required to decide if 
the outliers should be kept or not. 
• Missing value estimation: Missing values can be caused by signals that are below the 
detection limit of the instrument (True Missing) or because they were not collected. 
Bioconductor package, pcamethods, provides several algorithms for missing value 
imputation.  
• Data transformation: The normalization and transformations are performed to remove 
the non-biological variations and then make the data normally distributed. Metabolomics 
data can have various sources of uninduced variations like difference in abundance; 
metabolites in the central metabolism are more stable than the secondary metabolism, 
and large fluctuations under identical biological conditions, technical variations and 
heteroscedasticity. Range scaling is one of the most commonly used methods to give 
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equal importance to all the metabolites. Log transformation is also commonly used 
because it not only provides some scaling but also makes the multiplicative models 
additive and thus useful in removing heteroscedasticity (van den Berg R. et al. 2006) 
Pattern recognition and data mining:  
Unsupervised methods do not require any previous knowledge about the groups or classes that 
the data belongs to and can be used to summarize and find key features in the data and class 
discovery. Some of the popular unsupervised methods are described below:  
Clustering: 
 Clustering is used to group samples with similar metabolite profiles together. Clustering 
organizes the data into groups such that objects that are in a cluster are more closely related to 
each other than with the objects from the other clusters. To measure proximity many distance 
functions, e.g. Euclidian distance, Mahalanobis distance etc. are used. A good clustering results 
in the compact clusters that are also distant from other clusters. Some of the traditional 
clustering algorithms include hierarchical (HCA), k-means and self-organizing maps (SOM). 
HCA can be performed as an agglomerative methods or a divisive method. The agglomerative 
methods begin with each observation being considered as separate clusters and then proceeds 
to combine them until all observations belong to one cluster. Agglomerative methods are more 
commonly used in metabolomics studies. The divisive methods start with all of the observations 
in one cluster and then proceeds to partition them into smaller clusters. Some of the algorithms 
for HCA are average linkage, complete linkage, single linkage and Ward's linkage. Average 
linkage clustering uses the average similarity of observations between two groups as the 
distance measure between the two groups. Complete linkage clustering uses the farthest pair of 
observations between two groups to determine the similarity of the two groups. Single linkage 
clustering computes the similarity between two groups as the similarity of the closest pair of 
observations between the two groups. Ward's linkage uses an analysis of variance approach to 
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evaluate the distances between clusters. For example hierarchical clustering (HCA) was used to 
study volatile metabolites of 94 tomato genotypes which were obtained with Solid phase micro 
extraction (SPME-GC-MS). The first stage of clustering was helpful in removing the non-plant 
contaminant metabolites which were caused by the SPME fiber material. The HCA analysis 
resulted in two distinct clusters for the plant and non-plant metabolites. After removing the non-
plant metabolites from the data, hierarchical clustering was used again to cluster the genotypes 
(Tikunov Y. et al. 2005). Figure 2-2 shows an example of cluster analysis in of the data from 
2010 Arabidopsis Project  (www.plantmetabolomics.org) , where wild type samples under 7 
different conditions are compared against SALK_021108 mutant under the same 7 conditions. 
Two different linkage methods are employed in this analysis. We see that both the methods are 
able to put the most of the first 7 samples (Wild Type) and most of the next 7 samples (mutant) 
in different clusters. Low light mutant is clustering with low light wild type sample, which should 
be investigated further. 
 
 
Figure 2-2 Hierarchical Cluster Analysis (HCA) example  
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Principle Component Analysis (PCA) 
PCA transforms the high dimensional data into lower dimensions by finding the linear 
combinations of the original variables that maximize the variance within the data. The PCs are 
orthogonal and are ordered according to the variance explained. Therefore, the first PC explains 
the maximum variance. If the variance in the data reflects the true biological difference then 
plotting first PC against the second can be used to visualize the separation in the different 
classes. The original variables that contribute the most to the first few PCs are considered to be 
the most important. For example, PCA was used to analyze and normalize NMR data , which 
was followed by supervised discriminant function analysis using a priori information based on 
spectral replicates (Raamsdonk L. et al. 2001). Figure 2-3 shows the first two principal 
components of the data from 2010 Arabidopsis Project (www.plantmetabolomics.org) courtesy 
Dr. Oliver Fiehn’s lab at UC Davis. Wild type samples under 7 different environmental conditions 
are compared against SALK_021108 mutant under the same 7 conditions.  Six replicates in 
each condition were used. The wild type genotype is depicted by letter W and the mutant is 
depicted by letter M in the figure. We see that the first  two PCs  were able to separate the wild 
type samples and the mutant samples pretty well, but there are still some data points that are 
not separable which may be due to the nonlinear nature of the biological data. A scree plot 
shown in the figure 6 is generally used to determine the number of PCs. Figure 2-4 shows 
Scree plot of the PCA analysis from Figure 2-3. This plot shows that the first PC explains more 
than 30% variance in the data, second PC explains about 29% variance in the data and a 
combination of the first 5 PCs explain more than 90% of the variance in the data. 
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Figure 2-3 PCA Example 
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Figure 2-4 Scree Plot Example 
Classification 
PCA and clustering can visualize the separation of the samples according to the treatment 
factors (classes) but supervised methods are more powerful and can validate the separation 
numerically. The data is divided into 3 sets which are called training, test and validation sets. 
First the algorithm is trained using the training data and then class labels are predicted for the 
test data set. Some of the supervised learning methods are as following: Support Vector 
Machine (SVM) which tries to find the best hyper plane that maximizes the margin of separation 
between two classes. Decision tree (DT) algorithm branches the data and produces decision 
boundaries allowing the discovery of which metabolites are important. CART (classification and 
Principal Components 
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regression trees) and C4.5/C5 are the most popular decision tree algorithms. Other popular 
classification algorithms are artificial neural networks (ANN) and Random Forests (RF). ANN 
performs a good classification but does not explain the model very well, Tree based algorithms 
provide the rules but do not perform as well. 
Pathway Analysis 
• Pathway databases: The first step in pathway reconstruction is comparison with 
reference pathways like Kyoto Encyclopedia of Genes and Genomes (KEGG)(Kanehisa 
M.et al. 2004),  the ERGO system (Overbeek R. et al. 2003), BioCarta (BioCarta 2009), 
PathDB and the Roche Applied Science Biochemical Pathways chart which are available 
in digital form at ExPASy biochemical pathways page (Gasteiger E. et al. 2003). AraCyc 
(Zhang P. et al. 2005) and MetNetDB (Wurtele E. et al. 2007) are the most 
comprehensive databases to visualize biochemical pathways for Arabidopsis plants and 
has recently been expanded to include versions for all plant species (PlantCyc) which 
have sequenced genomes at the Plant Metabolic Network website (PMN_Team 2009). 
The software allows querying and the graphical representation of biochemical pathways 
and expression data MetaCrop (Grafahrend-Belau E. et al. 2008) is a hand curated 
database that summarizes diverse information about metabolic pathways in crop plants 
and allows automatic export of information for the creation of detailed metabolic models. 
• Metabolic Pathway modeling: The BRENDA database provides enzyme kinetics and 
substrate specificity database(Schomburg I. et al. 2004). 
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Abstract: 
PlantMetabolomics.org (PM) is a web portal and database for exploring, visualizing and 
downloading plant metabolomics data. Widespread public access to well-annotated 
metabolomics datasets is essential for establishing metabolomics as a functional genomics tool. 
PM integrates metabolomics data generated from different analytical platforms from multiple 
laboratories along with the key visualization tools such as ratio and error plots.  Visualization 
tools can quickly show how one condition compares to another and which analytical platforms 
show the largest changes. The database tries to capture a complete annotation of the 
experiment metadata along with the metabolite abundance data based on the evolving 
Metabolomics Standards Initiative (MSI). PM can be used as a platform for deriving hypotheses 
by enabling metabolomic comparisons between genetically unique Arabidopsis thaliana 
populations subjected to different environmental conditions. Each metabolite is linked to 
relevant experimental data and information from various annotation databases. The portal also 
provides detailed protocols and tutorials on conducting plant metabolomics experiments to 
promote metabolomics in the community. PM currently houses Arabidopsis metabolomics data 
generated by a consortium of laboratories utilizing metabolomics to help elucidate the functions 
of uncharacterized genes. PM is publicly available at http://www.plantmetabolomics.org. 
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Introduction 
In the post genomics era, metabolomics is fast emerging as a vital source of information to aid 
in solving systems biology puzzles with an emphasis on metabolic solutions. Metabolomics is 
the science of measuring the pool sizes of metabolites (small molecules of molecular weight 
<1,000 Da), which collectively define the metabolome of a biological sample (Fiehn et al., 2000; 
Hall et al., 2002).  Coverage of the entire plant metabolome is a daunting task as it is estimated 
that there are over 200,000 different metabolites within the plant kingdom (Goodacre et al., 
2004). Although technology is rapidly advancing, there are still large gaps in our knowledge of 
the plant metabolome.   
Despite this lack of complete knowledge and the immense metabolic diversity among plants, 
metabolomics has become a key analytical tool in the plant community (Hall et al., 2002).  This 
has led to the emergence of multiple experimental and analytical platforms that collectively 
generate millions of metabolite data points.  Because of this vast amount of data, the 
development of public databases to capture information from metabolomics experiments is vital 
to provide the scientific community with comprehensive knowledge about metabolite data 
generation, annotation, and integration with metabolic pathway data. Some examples of these 
public databases are given below. The Human Metabolome Project contains comprehensive 
data for more than 2000 metabolites found within the human body (Wishart et al., 2007). The 
Golm Database is a repository that provides access to mass-spectrometry (MS) libraries, 
metabolite profiling experiments, and related information from GC-MS (gas chromatography-
mass spectrometry) experimental platforms, along with tools to integrate this information with 
other systems biology knowledge (Kopka et al., 2005). The Madison Metabolomics Consortium 
Database contains primarily NMR spectra for Arabidopsis and features thorough NMR search 
tools (Cui et al., 2008). SetupX and Binbase provide a framework that combines MS data and 
32 
 
biological metadata for steering laboratory work flows and employs automated metabolite 
annotation (Scholz and Fiehn, 2007). 
A single analytical technique cannot identify and quantify all the metabolites found in plants. 
Thus, PlantMetabolomics.org (PM) was developed to provide a portal for accessing publicly-
available MS-based plant metabolomics experimental results from multiple analytical and 
separation techniques. PM also follows the emerging metabolomics standards for experiment 
annotation. PM has extensive annotation links between the identified metabolites and metabolic 
pathways in AraCyc (Mueller et al., 2003) at The Arabidopsis Information Resource (TAIR); 
(Rhee et al., 2003) and the Plant Metabolic Network (PMN, www.plantcyc.org), the Kyoto 
Encyclopedia of Genes and Genomes (KEGG), (Kanehisa et al., 2004), and MetNetDB (Wurtele 
et al., 2007).  
Standards for the annotation of metabolomics experiments are still under active development 
and the metadata types collected in PlantMetabolomics.org (PM) are based on the 
recommendations of the Metabolomics Standards Initiative (MSI) (Fiehn et al. 2007) and the 
Minimal Information for a Metabolomic Experiment, MIAMet (Bino et al., 2004) standards.  MSI 
attempts to capture the complete annotation of metabolomics experiments and includes 
metadata of the experiments along with the metabolite abundance data. The initial database 
schema design was guided by the schema proposed in the Architecture for Metabolomics 
(ArMet) project (Jenkins et al., 2004).  
 
Development of Plantmetabolomics.org: Rationale 
The rationale for the development of PM as an information portal is to provide free public access 
to experimental data along with cross-references to related genetic, chemical and pathway 
information. The portal also serves as an information resource for the field of metabolomics by 
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providing tutorials on how to conduct metabolomics experiments. It describes minimum 
reporting standards (Fiehn, 2007, 2007; Sumner, 2007) for plant metabolomics experiments 
based on the recommendations of the Metabolomics Standards Initiative (MSI). In addition, PM 
contains background information about the experimental design and tools that can be used to 
analyze the collected data (Helsel, 2005). To our knowledge, PM is the only plant metabolomics 
database that contains data from Arabidopsis metabolomics experiments that utilize multiple 
analytical detectors combined with different separation technologies. These include gas 
chromatography - mass spectrometry (GC-MS), gas chromatography-time-of-flight mass 
spectrometry (GC-TOF-MS), capillary electrophoresis-mass spectrometry (CE-MS), ultra high 
pressure liquid chromatography coupled to a hybrid quadrupole time-of-flight mass 
spectrometer (UPLC-Q-TOF-MS) and liquid chromatography-mass spectrometry (LC-MS) 
(Dunn and Ellis, 2005).  The statistical analysis and visualization tools are easy to use and aid 
non-statisticians in the analysis of the effects of different environmental conditions, genetic 
perturbations and other experimental factors. The information collected within PM can be used 
to form hypotheses about the roles of genes of unknown function in Arabidopsis by comparing 
the metabolome of a wild-type sample to that of a sample altered by a mutation at a target gene 
which can provide clues as to the function of that gene. The data (both biological and metabolic) 
and tools contained within PM, all available to the scientific community, are detailed in this 
paper. 
Design Requirements and Functionality 
PM allows users to explore and interpret data sets and put them in a biological context.  This 
requires the integration of relative metabolite abundance along with the metadata of the 
experimental conditions including growth, harvest and storage conditions of sample tissue, 
sample extraction, and instrument parameters. We also place an emphasis on ensuring ease of 
use and providing additional information about each identified metabolite by linking to other data 
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sources such as AraCyc, KEGG, MetNetDB and PubChem (Figure 3-1). The Metabolomics 
Standards Initiative (MSI) specifies the minimum amount of metadata from the metabolomics 
experiments that must be reported so that experiments can be replicated and results can be 
verified. These minimum data include descriptions of biological study design, sample 
preparation, data acquisition, data processing, and data analysis procedures. One goal of PM is 
to fulfill the outlined recommendations by the MSI.  Data contributors are required to use the 
standard data submission spreadsheet templates (available through the portal) to submit 
metabolomics data. These sheets follow ArMet and MIAMet specifications to capture the 
metadata of an experiment.  PM also includes educational video tutorials to aid metabolomics 
researchers in quality control. 
 
Figure 3-1  Diagram of the main components of the plantmetabolomics.org portal 
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PlantMetabolomics Content  
PlantMetabolomics in its current state houses the metabolite data generated from plant 
metabolomics experiments performed under the Arabidopsis 2010 program funded by the NSF. 
A consortium of metabolomics and metabolite profiling laboratories, in partnership with 
biochemists, biostatisticians and bioinformaticists, generated the data to formulate hypotheses 
about Arabidopsis genes of unknown function.  The consortium employed a strategy of 
generating Arabidopsis material at a single location followed by distribution to all analytical 
laboratories.  Different extraction processes and analytical techniques were used among the 
laboratories; ultimately providing analysis of roughly 1800 metabolites in each of the 
experiments conducted, around 400 of which are chemically defined. In total, among all 
experiments stored in the current database, roughly 3100 compounds were detected, including 
952 chemically defined compounds.  A total of 579 of the known compounds have been 
identified in AraCyc and many of them participate in  metabolic pathways described in that 
database. The metabolite data, along with the metadata, as generated by this consortium, are 
stored in the PM database.  
Experiment Annotation   
The pipelines used by the analytical laboratories in this consortium are captured through 
metadata for distribution via the database.  Each step of the process requires the collection of 
information to provide users with an understanding of collection, distribution and extraction of 
sample material, along with the instrumentation setup and data processing (Figure 3-2).  
Experimental metadata provides information about the growth and harvesting regimen, including 
the temperature, illumination, duration of growth, humidity and storage parameters, which were 
used to produce the Arabidopsis tissue samples for analysis.  This metadata also includes 
information that pertains to the genetic background of the samples.   
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The analytical metadata is collected in three sections: extraction, chromatography, and mass 
spectrometry metadata.  Each section includes details about the tissue sample extraction 
process and the instrumentation models, settings and parameters used for the chromatogram 
and spectrometer for each analytical platform.  
Each laboratory individually processes the metabolomics data obtained from the specific 
platform used.  Metabolite identification is based on procedures developed in each individual 
laboratory that utilize comparisons of retention time, retention index and mass fragmentation 
patterns compared to those of authentic standard compounds (when available) included in both 
private and public mass spectrometry libraries. Metabolite peaks that cannot be chemically 
annotated are given a unique identifier (Bino et al., 2004). The raw data is processed and 
normalized based on each laboratory’s instrument detection limit and analytical procedure.  
Specific processing procedures for each platform are available on the database on the protocols 
page.  The processed and normalized data from each laboratory has been collected for each 
experiment and loaded into the database. The public can access the data online or download it 
for use in other applications.  
Design of experiments:  
The plant metabolome responds to both environmental (E) and genetic (G) factors during plant 
growth.  Environmental parameters such as temperature, light intensity, growing medium, 
humidity and all other abiotic and biotic factors that affect plant growth and development are 
defined and stored. The genetic parameter is defined by the integrated expression of the alleles 
that encompass the organism’s genome. The design of experiments conducted by the above 
consortium took both the genetic and environmental parameters into consideration. Genetic 
parameters were manipulated by using Arabidopsis stocks that contained T-DNA insertions in 
either a gene of known function (GKF) or gene of unknown function (GUF) obtained from the 
Arabidopsis Biological Resource Center (ABRC; Columbus, OH).  The stocks were selected 
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based on availability and current knowledge and on gene predictions from sequence analysis 
and association networks (He, Lee, Walk and Rhee, manuscript in preparation).  All mutant 
stocks were visibly screened for phenotypes that resembled wild-type seedlings. Pictures of 
each mutant line at 17 days after sowing are available within PM.   
 
Figure 3-2  Schematic representation of the process used in generation of metabolite data  
PM currently contains metabolomics data from two types of experimental designs that varied the 
G*E interactions (Table 3-1).  The first setup used a combination of G*E variations, where the 
genetic parameter was comprised of two different genotypes (wild-type and one mutant stock) 
and the environmental parameter was changed in a single abiotic or biotic manner.  The 
experiments that fall into this first category provide information on the overall effect that both the 
environment and genetic parameters have on the metabolome of Arabidopsis seedlings.  The 
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second setup, which encompasses a large percentage of the data, varied only the genetic 
parameter and kept the environmental conditions constant during the growth period and across 
all experiments.  Each experiment contained wild-type seedlings along with 8-15 seedlings 
representing Arabidopsis stocks carrying T-DNA mutant alleles. Holding the environment 
constant and varying the genetic parameter provides metabolomic data that is a consequence 
of the genetic change and can therefore provide information about the consequence of mutating 
a specific gene within each stock. 
 
Experimental Data 
Metabolite abundance data can be downloaded along with the metadata for each experiment 
contained in PM.  There are three options for downloading metabolite abundance data.  The first 
option allows the users to select and download data from specific experiments and/or analytical 
platforms. The downloaded file contains the user-chosen results compiled in a comma 
separated values (csv) format. This option also allows users to download the correlation 
coefficients between the various replicates along with the data. Once they download the csv file 
they can look at the correlation coefficients and determine if they want to exclude part of the 
data if the correlation among the replicates is low. PM does not exclude any data based on the 
data quality issues but equips the users with the analysis tools and measurements so that the 
users can make informed decisions. The second option allows users to download the compiled 
Excel workbooks for individual experiments that contain a single sheet for each analytical 
platform. The workbooks contain the original data as submitted by the respective labs.  This 
option provides the data in an easy to use format that can be manipulated by the user for their 
own analyses. The third option comes in the form of a compressed file (.zip) that provides 
partially processed data for each of the mutant experiments.  This download includes: 1. The 
further scaled metabolite abundance data which reduces the variation within biological 
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replicates; 2. Scatter plots and correlation coefficient values between biological replicate data 
that provide additional information about the consistency of the replicates; 3. All the metabolites 
with false discovery rate (FDR) adjusted t-test p-value and ratios between mutant and wild type, 
so that users can define the significantly altered metabolites by combining the p-value and ratio 
(fold-change); 4. MVA-plots that show changes in metabolite abundance by displaying the log 
concentration ratio vs. the average log concentration across replicates. Detailed information 
about the data processing can be found in the readme.doc file included in the datasets.  
Table 3-1 Experimental set-ups used to generate metabolomics data contained in PM 
 
Experiment 
Name 
Factors Varied 
Environmental (E) Genetic (G) Total (GxE) 
EIE2 7 2 14 
Fatb Induction 2 2 4 
Elo1 Induction 3 2 6 
ME1 1 9 9 
ME2 1 11 11 
ME3 1 16 16 
ME4 1 14 14 
ME5 1 11 11 
. 
Tutorials 
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The database contains tutorial information about the methodologies for the metabolomics 
studies developed by the consortium. These methodologies reflect metabolomics’ utility in 
functional genomics and the current state of the technology. Metabolomics is not yet a widely 
utilized technology and it is thus important to train researchers in the methodologies, 
technologies, and standards in metabolite profiling. This ensures laboratory-to-laboratory 
reproducibility and facilitates meta-analyses across multiple experiments. 
Three video tutorials demonstrate the methods used for tissue harvesting and distribution.  The 
experimental metadata describes in detail the process used for harvesting tissue material and 
the “Tissue Harvest” video tutorial provides a visual guide for this process.  This tutorial details 
the process used to open Petri dishes containing sample material, to collect the tissue and to 
immediately halt metabolism by submerging the tissue in liquid nitrogen. This process is 
completed within <2 minutes as seen by the elapsed time on the timer. Each laboratory requires 
specific amounts of tissue for each analytical platform.  Collected samples must be weighed and 
sorted for shipment to the analytical laboratories. The two video tutorials “Sample weighing and 
Sorting of tissue samples” and “Sample Weighing (Closer View)” provide a visualization of this 
process.  The three video tutorials provide an experimentalist with an additional tool to 
understand and repeat the process used to generate tissue samples required for metabolomics 
experiments. 
The web portal also provides tutorials on how to browse, download and visualize the 
available data. These tutorials are provided as help buttons on all the main function pages as 
well as under the main “Tutorials” menu option.  Many examples and screen shots of resulting 
pages are provided in the tutorials. 
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Data Analysis and Visualization of Experimental Data 
The data analysis and visualization tools permit an analysis of data quality and hypothesis 
generation with dynamic graphs, which can be automatically generated with easy to use 
graphical user interfaces (GUIs). 
Users may compare metabolite levels under different experimental conditions through the 
generation of dynamic ratio plots of the metabolites using the GUI. Users can choose any two 
experimental factors to compare and select specific analytical platforms to include in the 
analysis.  The resulting ratio plot shows the abundance data (Figure 3-3). The x-axis shows the 
logarithm (base 2) ratio of the relative abundance of each metabolite between the mutant and 
wild type samples selected (see Materials and Methods).  The metabolites that have a relatively 
low fold change between the two factors are close to the central vertical y-axis and the 
metabolites that have a relatively high-fold change are distant from the central vertical y-axis.  
The metabolites with one or more replicates with missing values are shown with different 
colored marks for quick inspection of data quality.  
A summary of the metabolite abundance data is generated along with the ratio plot.  This 
summary contains metabolite names that can be ordered according to the number of missing 
values (1, 2, 3 or more, or all null values). Detailed metabolite information is available by clicking 
on its name on the list or on the glyph on the ratio plot. 
The error plot shows the change in the metabolite abundance level among the replicates. This 
helps the users to see if the significant change in the metabolite abundance is similar in 
replicate samples. The metabolite abundance data can also be visualized in a bar chart (Figure 
3-4) where metabolite abundance under different experimental parameters is shown for each 
replicate. 
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The metabolite details page also provides links to other databases to give users access to more 
details about the metabolites.  These links include metabolic pathway information from Aracyc 
and MetNetDB and compound information from PubChem, CAS, KEGG, and ChEBI. The 
names of all the pathways that contain a metabolite are shown on the metabolite annotation 
details page. Links to experimental data for all the other metabolites that participate in that 
pathway are also provided. 
 
Figure 3-3 Ratio Plot   
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Figure 3-4 Metabolite details of Methionine   
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Data Quality Checks:  
PM provides many options where a user can check the variability between different replicates 
(Figure 3-5) or see if some of the replicates are below the detection limit (Figure 3-3). The 
ultimate decision to exclude the data is left with the users. The data quality plots are provided 
along with the data. The ratio plot discussed in the previous section also provides instant access 
to replicates that are below the detection limit by showing them in different colors. A summary 
list provided with the ratio plots groups metabolites according to the number of missing values. 
The list can be ordered by the metabolite names to find if the same metabolite is detected by 
several platforms.  
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Figure 3-5 Replicate quality check 
 
Query Capabilities 
The database can be queried by individual metabolite or pathway names.  This feature helps an 
investigator search for a particular metabolite across different experimental conditions.  Once 
the metabolite is located in an experiment, the investigator can identify the pathways in AraCyc 
and MetNetDB in which this metabolite participates.  The pathway search option finds all 
metabolites in the PM database that are part of the same pathway.  The portal contains a local 
copy of AraCyc synonyms for metabolites along with the web links to AraCyc.  This helps in 
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searching for metabolites by either the names by which they are stored in the PM database or 
any of the synonyms that can be resolved by AraCyc. The local copy is updated every 4 
months. 
Conclusions 
One of the most important functions of any metabolomics database is to present collected data 
in a way that allows it to be used for comparison among different experiments and platforms.  
This requires that all metadata of standard operating procedures for sample preparation, data 
acquisition, and data processing be made available along with the corresponding results.  
Although there are some commercially available databases (Ridley et al., 2004), to our 
knowledge, PM is one of the first metabolomics databases available in the fundamental plant 
research arena.  The database combines the results from many different platforms that were 
used in parallel to analyze the same biological material.  At the end of the two-year pilot study, 
we have been able to provide data from 50 mutant lines and to capture baseline variations in 
metabolism in response to environmental condition variations during plant growth and tissue 
harvest.  Web-based visualization tools in the portal make it easy for a non-statistician to do 
initial exploration of the data, perform quality checks and generate hypotheses. This platform 
not only provides the metabolomics data and the analysis tools, it also promotes the field of 
metabolomics by providing educational tutorials on performing the metabolomics experiments 
and implementing the MSI standards. We acknowledge that some of the data from the pilot 
project has low reproducibility between the replicates therefore the users are guided to carefully 
evaluate the data quality with easy to use visualization tools and tutorials so they can make 
educated decisions about exclusion of data from their analyses. 
The metabolomics consortium expects to profile additional Arabidopsis mutant lines and upload 
the data to PM as it becomes available.  We plan to enhance the resource by adding the 
derived spectral peak location, mass-spectra, and metabolite peak integration data as well as 
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make the actual chromatograms available for download in community accepted formats such as 
NetCDF and mzML. We plan to add more analysis and visualization tools to make this portal a 
better aid for generating hypotheses and promoting the field of metabolomics within the 
community.  The web portal is also ready to accept MSI-compliant metabolomics data from 
other MS based metabolomics platforms for Arabidopsis and other plants. 
Materials and Methods 
Normalization and data processing 
 Metabolomics data generated are normalized and processed according to each specific 
laboratory’s protocol.  This process is detailed for each individual analytical platform and 
laboratory in the standard operating procedure protocols contained within PM.   
 
Missing Values: 
The detection limits for every run are typically experimentally determined by the corresponding 
labs and are reported along with the metabolite data. Missing values or below-detection limit 
measurements are replaced by ½ of the estimated detection limit if the detection limit is reported 
for that run; otherwise the missing values are replaced by ½ of the lowest value for that run 
(Helsel, 2005). 
Ratio Plot 
 
The x-axis ordinate is the logarithm (base 2) of the ratio of the relative abundance of each 
metabolite in the wild type vs. mutant plant: 
2log mt
wt
x axis µ
µ
 
− =  
 
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The values, µmt and µwt, calculated for each metabolite in each platform, are the sample means 
for the metabolite abundances of the replicates in the mutant and wildtype, respectively.  
 
Error Plots 
 
The standard error (SE) of the log-ratio was calculated using the delta method (or one-step 
Taylor-series) approximation, 
2 2
1
ln(2)
mt wt
mt wt
SE SE
SE
µ µ
   
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SEmt and SEwt are the standard errors of the average mutant and wild-type metabolite 
abundances calculated by: ( ) ( )
21
1
1
N
i xN N
i
SE x µ−
=
= −∑ , where N is the number of replicates. 
 
Compound Curation in AraCyc 
The experimentally verified Arabidopsis compounds identified in the PM project were added into 
a broader metabolic pathway framework in AraCyc by first matching the names of PM 
compounds to existing compounds in the database to link the two resources. Named 
compounds that were not found in AraCyc were investigated using several resources such as 
MetaCyc (Caspi et al., 2008), SciFinder Scholar (Wagner, 2006), Chemical Entities of Biological 
Interest (Degtyarenko et al., 2008)(ChEBI, EMBL-EBI), PubChem (NCBI), and KEGG(Kanehisa 
et al., 2004) to find chemical structures and synonyms. These compounds were entered into 
AraCyc and linked to PM. Compound names that describe multiple structures that cannot be 
conclusively distinguished in the metabolomics experiments were entered as “classes”. These 
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contain the chemical formula of the identified compound, a text description, and, if possible, a 
partial structure using “R groups” to denote structural ambiguities. To place these compounds 
into the appropriate metabolic context, we searched the scientific literature and the databases 
used for compound identification. In addition, specific reactions between identified compounds 
were made based on generic reactions present in AraCyc. 
Data Curation  
 Data is sent to the administrators using the sample spreadsheets. The spreadsheets are 
verified for format and then uploaded in the database by the administrators. The collaborators 
cannot upload the data themselves.  
Supplemental Data 
The following materials are available with this article. 
Data Base Schema 
The main structure and data organization of the PlantMetabolomics database are attached in 
Appendix–Supplementary Documents S1. 
Website Map 
The website map of PlantMetabolomics.org is attached in Appendix–Supplementary Documents 
S2. 
How to use the web portal 
A case study is provided in Appendix– Supplementary Documents S3. 
 
 
 
 
50 
 
Acknowledgments 
This work was performed at the Virtual Reality Application Center, Iowa State University with the 
assistance of the Bioinformatics Laboratory of the Bioinformatics and Computational Biology 
program. 
  
51 
 
Supplementary Document S1:  Data Base Schema 
 
 
 
Figure 3-6 Database Schema 
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Supplementary Document S2:  PM Website Map 
 
 
WWW.Plantmetabolomics.Org     
News   
Collaborators 
FAQ   
Publications  
 Links  
 Browse  
 Download  
Biology Metadata 
 Extraction Metadata  
MS Metadata   
Chromatography Metadata   
 Download 
 Submit Data  
Chromatography Metadata  
BiologyMetadata.doc  
ExtractionMetadata.xls  
MSMetadata.xls  
MetaboliteData.xls  
Plot Metabolite Ratios  
 Tutorials  
Gene targets  
Search  
Feedback  
 
Figure 3-7 Website Map  
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Supplementary Document S3: Applications of PM and Availability of 
Metabolomics Data: Case Study 
 
Case study: Visualize the difference in metabolite levels under two different stress conditions 
Scenario: An investigator is interested in how the metabolome changes when comparing mutant 
and wild-type samples. Specifically, the investigator wants to know which metabolites show a 
significant change and which biochemical pathways they are involved in.  The investigator is 
also interested in obtaining detailed information about specific metabolites from other web 
sources, other metabolites in the relevant biological pathways, and all the metadata associated 
with the selected mutant sample.  
For example, the investigator is interested in the metabolome changes for mutant 
SALK_003718, which has a T-DNA mutation in the Arabidopsis gene At3g16950 which encodes 
a plastid lipoamide dehydrogenase, compared to the combined wild-type samples, WtCol01 and 
WtCol02, in Mutant Experiment #3 (ME#3).  Below is a detailed description of a possible 
analysis path. Please note that analyses do not need to be done in this order.  Help icons are 
located throughout the database to aid users in understanding the tools available at PM.   
In the main web page, www.plantmetabolomics.org, the investigator first clicks on the “Tools” 
menu followed by “Plot Metabolite Ratio” on the menu option. To generate a ratio plot, data 
must be selected from individual experiments, for this example clicking on the drop down box by 
the experiment name “Mutant Experiment #3” allows the investigator to select the control 
(WtCol01) and the mutant (SALK_003718).  By default, all metabolite profiling platforms for this 
experiment are selected, but the investigator can exclude/specify platforms.  By clicking submit, 
the ratio plot is generated.  Before submitting, the investigator can view the metadata for a 
54 
 
specific experiment by clicking on the experiment name. In this example, only the platform for 
amino acids is selected. 
The ratio plot (Figure 3-3) contains all metabolites analyzed within the selected platforms (in this 
case, the amino acid platform in ME#3).Metabolite names appear by moving the cursor over the 
plotted points. Contained within this page is a summary of the data quality. Missing or below 
detection limit values are depicted by different colored marks on the plot. The right side of the 
page shows summary information in a list form. This data can be downloaded as a text file by 
clicking on the download button on top. This list groups the metabolites according to number of 
replicates that are below detection limit. This list also shows the fold changes between the 
mutant and the control and be easily sorted.  Each point in the ratio plot or the metabolite name 
in the summary list is clickable and advances the investigator to the metabolite details page 
(Figure 3-4).  For this example, the investigator clicks on the metabolite methionine, which is at 
the 13 point on the y-axis and has a 1.5 fold change between the samples SALK_003718 and 
WtCol01.  The investigator is advanced to the metabolite detail page for methionine (Fig. 3.4).  
This page contains information about the molecular weight, chemical formula, CAS registry 
number, SMILES (Simplified Molecular Input Line Entry System) notation and pathway 
information for this specific metabolite.  It also provides links to other databases including 
AraCyc and the LIGAND database from KEGG. The bar chart at the bottom of this page graphs 
the abundance level of methionine for each replicate of all the samples profiled in ME#3. Since 
a metabolite can be detected by multiple analytical platforms, the investigator can search for 
that metabolite using the “Search” functionality. The resulting page provides links to the 
metabolite details page where the data can be visualized for each analytical platform in bar 
charts as described above.  The downloaded summary list is also helpful in finding a metabolite 
that is detected by multiple platforms. Since the different platforms use different extraction 
procedures, the amount of fold change can be different in different analytical platforms. In our 
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example, the downloaded summary list shows that methionine is detected by 3 analytical 
platforms in ME#1 and ME#2. The investigator can do a quick quality check of the platform at 
this time by generating the “Scatterplot of replicates” for SALK_003718 and WtCol01 lines in the 
3 analytical platforms that detect it and make a decision to exclude any replicates that do not 
have a good reliability. 
From the pathway information for methionine found on metabolite detail page, the investigator 
can search for other profiled metabolites involved in the “tRNA charging pathway”. The resulting 
page shows all the other metabolites in the PM database that belong to the given pathway. The 
investigator can download the CSV file of this data using the “Download” button provided at the 
top of the resulting page. 
Metabolite abundance information can be downloaded by clicking the “Download” link on the top 
of the results or by clicking the “Download” menu option on the main page.  
Following these steps provides a detailed analysis of a single mutant sample.  A comparison of 
all the metabolites profiled by the consortium in a mutant sample to that of wild-type gives an 
overall view of the changes that are occurring in the metabolome of this mutant line.  
Biochemical mapping of the metabolites that are hyperaccumulating and hypoaccumulating 
compared to wild-type provides preliminary evidence of the biochemical pathway the target 
gene may be associated with, thus leading to an initial hypothesis about the function of that 
target gene.   
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CHAPTER 4. PLANTMETABOLOMICS.ORG:MASS SPECTROMETRY 
BASED ARABIDOPSIS METABOLOMICS-DATABASE AND TOOLS 
UPDATE 
A paper published in  Nucleic Acid Research 2012 database issue 
Preeti Bais, Stephanie M. Quanbeck, Basil J. Nikolau, and Julie A. Dickerson 
 
Abstract  
The PlantMetabolomics (PM) database (http://www.plantmetabolomics.org) contains 
comprehensive targeted and untargeted mass spectrum metabolomics data for Arabidopsis 
mutants across a variety of metabolomics platforms. The database allows users to generate 
hypotheses about the changes in metabolism for mutants with genes of unknown function. 
Version 2.0 of PlantMetabolomics.org currently contains data for 140 mutant lines along with the 
morphological data. A web-based data analysis wizard allows researchers to select 
preprocessing and data-mining procedures to discover differences between mutants. This 
community resource enables researchers to formulate models of the metabolic network of 
Arabidopsis and enhances the research community's ability to formulate testable hypotheses 
concerning gene functions. PM features new web-based tools for data-mining analysis, 
visualization tools and enhanced cross links to other databases. The database is publicly 
available. PM aims to provide a hypothesis building platform for the researchers interested in 
any of the mutant lines or metabolites. 
Introduction 
PlantMetabolomics.org stores the data from an NSF-funded multi-institutional consortium that is 
developing metabolomics as a functional genomics tool for elucidating the functions of 
Arabidopsis genes without visible phenotype. The consortium has established mass 
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spectrometry based metabolomics platforms that detect approximately 2000 metabolites, of 
which ~1000 are chemically defined [1]. The consortium generates the Arabidopsis biological 
material at a single location followed by distribution to the analytical laboratories for targeted 
and untargeted analyses. Phase 1 focused on investigating the robustness of the Arabidopsis 
metabolome, and defining the conditions that minimize the environmental and developmental 
effects. Subsequently, the consortium profiled the metabolome of specific T-DNA knockout 
alleles for these targeted genes [2]. These MSI-compliant metabolomics data [3, 4] are 
integrated with phenotypic data and data concerning protein function, transcription and other 
studies to help users generate hypotheses concerning the functions of the targeted genes. 
The updated PlantMetabolomics.org database features new datasets and morphological 
information for the plant community along with new web-based analysis tools. These tools 
include clustering and classification tools to distinguish between different mutants as well as 
determining which metabolites best differentiate the mutant. New visualization tools include ratio 
plots of metabolites and CytoscapeWeb [5] pathway visualization of metabolites on the AraCyc 
pathways [6]. 
Database Contents 
PlantMetabolomics.org contains mass spectrometry based metabolomics concentration data for 
140 novel single-knockout gene mutant lines in Arabidopsis. 53 the lines are novel since the last 
release and 35 were repeated to increase the number of replications. Approximately 998 known 
metabolites and 2020 unknown metabolites were detected using 7 different MS-based platforms 
for each of these mutant lines. The number of replicates for each line was also increased from 3 
replicates to 6 replicates.  
The database has also added morphological image data including features of the mutants’ 
leaves, cotyledons and roots at 16 days after imbibitions (DAI) and mature seeds using an 
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Olympus stereomicroscope with reflected and transmitted light sources and a high-resolution 
digital color image and scanning electron microscope.  Digital camera images of the roots of all 
the Arabidopsis thaliana tissue were collected at 6, 9, 13 and 16 days after imbibitions (DAI) in 
pixels and these were converted from pixels to root length measurements using Image J 
software [7]. A user can select a gene and compare its morphological images with the images 
from the wild type samples using a side by side image analysis tool in the database which is 
accessible from the when the user searches for a gene of interest from the home page or uses 
the search functionality to search for a gene. 
New annotation links to LipidMaps [8] have been added for metabolites. Structurally known 
metabolites have been annotated with metabolic pathway information from the AraCyc database 
(version 8.0) [6].  This annotation helps users understand how changes in a metabolite might 
affect the metabolism of the entire organism. Figure 4-1 shows an example of the new 
annotation and the images. 
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Figure 4-1  Visualization tools 
Analysis Tools for Metabolomics 
PlantMetabolomics.org includes new web based data analysis tools to aid a researcher in 
generating hypothesis about the metabolomics signature of a mutation. The data analysis 
wizard provides various options to normalize and preprocess data along with many choices of 
multivariate data analysis methods along with step by step guidance on the analysis pipeline. 
Default choices are provided at each step and the downstream analyses are made available 
only after the necessary preprocessing steps have been successfully performed. All the analysis 
results and figures are made available for download at the end of the analysis. The data 
analysis tool is developed with PHP and the R programming environment [9]. 
Data Preprocessing: The data preprocessing steps involve missing value imputation and 
normalization. For missing value imputation, the user selects a threshold to eliminate 
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metabolites that have a higher percentage of missing values than the threshold (e.g., for a 
threshold of 50%, a metabolite with 4 or more missing values out of 6 will be removed from 
further computation). For cases where there are fewer missing values, the missing values will 
be imputed by mean of the concentration for that metabolite over the remaining values.  The 
next step is data normalization. Data normalization weights the metabolites to emphasize 
different attributes of the data. Common choices described in [10], Range Scaling, Pareto 
Scaling, and Auto Scaling, help weight metabolites equally regardless of overall abundance. 
Log Transformation is used to correct for heteroscedascity and make multiplicative effects 
additive. The equations and a discussion of each method are accessible from the “?” icon in the 
data analysis wizard. After the preprocessing and normalization steps, a user can choose one 
or more of the analysis tools to analyze the data. Examples have been provided at each data 
mining step to help users interpret their results. 
Clustering Analysis: Biologists can generate hierarchical clustering plots to see which mutants 
are statistically close to each other and have similar metabolic profiles. Multiple choices for 
distance measure (Euclidean and Manhattan) and for the linkage method (Ward, complete, 
single, average, median, and centroid) are available. The goal is to group or segment a 
collection of samples (mutants) into subsets or "clusters", such that those within each cluster 
are more closely related to one another than objects assigned to different clusters. The result of 
clustering is presented as a dendrogram that a user can download from the PM website. Figure 
4-2 A shows an example of a dendrogram using hierarchical clustering analysis tool with 
average linkage and Euclidean distance parameters. 
Multi-Dimensional Scaling (MDS): A MDS plot is a commonly used multivariate exploratory 
data analysis tool. MDS is an exploratory multivariate data analysis method that is used in 
visualizing the structure of relations between entities by providing a geometrical representation 
of these relations in a lower dimensional space[11]. An MDS plot shows the similarities or 
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dissimilarities in data in two dimensions. In this case, the MDS plot shows statistical distances 
among samples based on their metabolomes’ signatures (Figure 4-2 D). Commonly used 
distance measures (Euclidean and Manhattan) are provided for this tool as well.  
Principal Component Analysis (PCA): PCA is one of the most commonly used methods used 
in high dimensional data analysis [12]. PCA provides a low dimension view of the 
multidimensional data by mathematically transforming a number of correlated variables into a 
smaller set of uncorrelated variables which are called Principal Components (PCs). A user can 
generate PCA plot against the first two principal components and also the scree plot that show 
the percentage of variability explained by subsequent  principal components. The PCs are 
orthogonal and are ordered according to the variance explained. Therefore the first PC explains 
the maximum variance. If the variance in the data reflects the true biological difference then 
plotting first PC against the second can be used to visualize the separation in the different 
classes. The original variables that contribute the most to the first few PCs are considered to be 
the most important.  The PCs can be downloaded for further analysis. Figure 4-2 B shows an 
example of PCA loadings plot for the first two PCs. 
Random Forest Classifier: Random Forests are used in metabolomics for classifying mutants 
into different classes [13]. A Random Forest Classifier is an ensemble of classification trees 
[14]. Random Forests work well for classification when the number of features is much greater 
than the number of observations and they have good predictive performance even when most 
input variables are noisy[15]. Of importance to biologists is that the output is easy to understand 
because it does not transform the metabolite data and the output ranks variables that are 
responsible for classification.   
The classification trees are built using a bootstrap sample of the data generated by using 2/3rd 
of the data for sample generation and keeping the remaining 1/3rd of the data for testing.  A 
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small subset of the variables is used in building a tree. The random Forest R package provides 
classification analysis between two or more types of samples (e.g., Wild Type and a Mutant line) 
[16] and generates the variable importance score plots of the key metabolites (Figure 4-2 
C).The list of top 30 key metabolites is also made available along with the annotations for the 
metabolites. One can click on a metabolite name on this list and see its annotation from various 
external databases such as KEGG, AraCyc and Lipid Maps. The automatically generated ratio 
plot shows the metabolite’s behavior in the other mutants as compared to wild type samples. 
The complete list can be downloaded by clicking at the download file link and used in other 
applications. The random forest classifier can also be downloaded along with the number of 
correctly classified and misclassified samples in each class. 
Download Results: At the end of analysis, the user can download all the results along with 
comma separated data files and as well as the R code used at each step of the analysis. 
Examples are also provided at each step to help the users with the interpretation of their results. 
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Figure 4-2  Data analysis tools 
Visualization Tools for Metabolomics 
New data visualization plots were added so a user can select a metabolite and see its behavior 
in 140 different mutations in a single plot (as a ratio of mutant and wild type samples). Similarly, 
a user can select a gene and see the behavior of all the metabolites (as compared to the wild 
type samples). After selecting a gene of interest, a user is taken to gene details page where 
they are shown the morphological data along with a log-ratio plot of the data. In the log-ratio plot 
for a gene, each point shows the log-ratio (to base-2) of a metabolite’s abundance in the 
(mutant sample):(wild-type sample).  The points are color coded according to the number of 
missing values for each metabolite and provide an instant data quality check. Clicking on a point 
in the log-ratio plot takes the user to a page where annotation of that metabolite with the 
information about its participation in pathways and links to other databases like KEGG [17] ), 
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LipidMaps [8], and PUBCHEM [18] are shown. The metabolites are annotated with a local copy 
of the AraCyc database [19] which was updated to the latest release of version 8.0 of AraCyc.  
Single metabolic pathways from AraCyc can also be viewed using CytoscapeWeb [5] and 
PathwayAccess tools[20]. From the annotation page, a user can select a pathway that contains 
their metabolite of interest and view the pathway with their metabolomics data superimposed for 
any of the experiments in the database. 
Conclusions and Future Developments 
This updated version of PlantMetabolomics.org provides metabolomics mass spectrometry-
based metabolomics data from multiple analytical platforms. A user can analyze this data using 
our web based data visualization and mining tools and generate the hypothesis about the 
functions of gene of their interest. A user can also perform a comparative analysis on a 
metabolite or metabolic pathway of interest and see their behavior under different mutations. 
We plan to enhance our coverage mutant lines to 203 novel lines.  
The next steps for this database are to create a viewer for extracting the spectra of the 
measured metabolite from the different platforms and replicates. This will create a valuable 
resource for mass spectra across many different platforms and gather information on 
measurement variability. This capability may allow PlantMetabolomics.org to link to the spectral 
data in the LC-MS Arabidopsis database, AtMetExpress [5] and the GC-MS Golm Metabolomics 
Database [23]. The flexibility of the pathway viewer will also be enhanced to give the user more 
ways to combine pathways into networks and select data. 
Availability 
The PlantMetabolomics.org database is available online and free to all without restriction at: 
http://www.plantmetabolomics.org/. 
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List of Figures 
Figure 4-1:  Visualization tools:  (A) Log-ratio plot of a metabolite (PA 34:2) where each point 
shows the ratio of the concentration of the given metabolite in mutant samples vs. the wild type 
samples. The highlighted mutant line (SALK_040250) looks interesting as it is away from the 
central vertical axis and thus depicts difference between mutant samples and the wild type 
samples.  (B) The user can instantly access the stereomicroscopic images for this mutant and 
compare them with wild type samples. Seed images at 250 X zoom of mutant’s seeds look a 
little distorted as compared to the wild type seeds (Seed image courtesy of Jennifer Robinson). 
(C) The user can also access the details of the metabolites including cross links to other 
databases.  (D) Clicking on any of the points in the log-ratio plot in (A) shows the log-ratio plot of 
all the metabolites for that mutant. For example, some fatty acids including tetradecanoic acid 
look interesting for this mutant as they are away from the central vertical axis and show large 
fold change between the wild type and mutant samples. 
Figure 4-2: Data analysis tools: (A) Hierarchical clustering of lipidomics data from the Welti Lab 
compares SALK_040250 (At1g61720) mutant line with wild type samples using Euclidean 
distance and average linkage method. (B) PCA loadings plot of the first two PCs shows that the 
wild type and mutant are not linearly separable. (C) Important metabolites for the classification 
between wild type and the mutant line using the Random Forest tool shows that the most 
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important variables are glycerophospholipids with chain lengths of 34 and 36. (D) MDS plot of 
the mutant and wild type samples using the Manhattan distance measure which shows that the 
mutant and wild type are not separable and that there is an outlier in the data.  
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CHAPTER 5. DATA ANALYSIS PIPELINE IN FUNCTIONAL GENOMICS 
USING METABOLOMICS AND MACHINE LEARNING 
A paper to be submitted to Plant Physiology 
Preeti Bais, Basil Nikolau, David J. Oliver, Julie A. Dickerson 
Abstract: 
This analysis presents a biomarker discovery pipeline that uses machine learning and 
metabolomics to discover biochemical changes in a cell due to a single gene knock-out 
mutation in Arabidopsis. Since a single metabolomics technique cannot cover the whole 
metabolome, multiple mass spectrometry based metabolomics platforms are integrated 
together to get biomarkers of a mutation across a wide range of metabolite families. The use 
of different metabolomics platforms increases the coverage of the metabolome but multiple 
platforms present significant challenges on integrating data across the platforms. Different 
strategies for integrating the metabolomics abundance data from multiple platforms are 
compared to find the ideal method for biomarker discovery.  The Random Forest machine 
learning algorithm is used for classification of mutant and wild type samples and to generate 
reproducible models with a small set of metabolites that are responsible for the 
classification.  Unknown metabolites are a serious problem in any large scale metabolomics 
analysis as they do not provide any biological insight. Partial correlation networks are used 
in putatively identifying the unknown metabolites without the need for expensive and time 
consuming methods like NMR.  
         A proof-of-concept analysis on the  oxoprolinase (oxp1) and gamma-glutamyl 
transpeptidase (ggt1 and ggt2) single gene knock-out mutants in the glutathione 
degradation (GSH) pathway of the Arabidopsis confirms the known biology that OXP1 is 
responsible for conversion of 5-oxoproline (5-OP) to glutamic acid. In addition, ggt1/ggt2 
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analysis supports the hypothesis that the GGT genes may not be major contributors for the 
5-OP production. Also, the ggt2 mutation does not appear to alter the biochemical profile of 
the cells in comparison to the wild type samples, supporting the previous studies that it may 
have low level expression in the leaf tissues. 
This data analysis pipeline is implemented in a web based metabolomics analysis and 
visualization suite of tools at www.plantmetabolomics.org. 
Keywords: Metabolite Profiling, Arabidopsis, Machine Learning, GC-MS, LC-MS, Random 
Forests, Oxoprolinase, Correlation network
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Introduction 
Metabolomics is the science of measuring the pool sizes of metabolites (small molecules of 
molecular weight <1,000 Da), which collectively define the metabolome of a biological sample 
(Fiehn et al. 2000; Hall et al. 2002). Under stable environmental conditions, comparing the 
metabolome of a wild-type sample to that of a sample altered by a mutation at a target gene can 
provide clues as to the function of that gene (Bino et al. 2004). Metabolomics aims to capture 
the final outcome of the genes at the biochemical level and the metabolomics based biomarkers 
can provide an understanding of the biochemical networks involved in a cellular process. Since 
a single analytical technique can not cover all the metabolites of a biological system, multiple 
mass spectrometry (MS)-based metabolomics analytical and separation techniques were used 
on identical plant material to understand the gene functions (Bais  et al. 2010). Different 
strategies of platform integration are compared to find the ideal method that not only classifies 
the mutants from the wild type samples with most accuracy but also provides the most 
biologically meaningful subset of metabolites for the classification.  
Random Forest (RF) classifiers are used in classifying the mutant samples from the wild type 
samples and finding the key metabolites for the difference (Beckmann et al. 2007). RF 
classifiers have been shown to create usable models using metabolomics data (Enot et al., 
2006, Scott et al. 2010). RF classifiers are non-linear classifiers which keep the features (i.e., 
metabolites) distinct and provide an importance ranking for the effectiveness of each feature. 
Finally, putative identifications for key unknown metabolites are provided by using a large scale 
partial correlation analysis across multiple mutation lines and manual inspection of the mass 
spectra.  This helps in incorporating the unknown metabolites in understanding the biological 
significance of the biochemical difference between the mutants and the wild type samples. 
Other methods of structure determination of metabolites include MS-MS analysis or NMR which 
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are expensive and time consuming. Using the partial correlation networks across many different 
mutant lines to find if the key unknown metabolites are closely related to any known metabolites 
helps in hypothesizing the biological role of the unknown metabolites with the existing data. 
Materials and methods 
Plant Materials 
The oxp1 mutant (SALK_078745), the ggt1 mutant (SALK_004694) and the ggt2 mutant 
(SAIL_6_G02) have been described and characterized earlier (Ohkama-Ohtsu et al. 2007a, 
2008) and were a result of T-DNA insertion into col-0 (ecotype Columbia:col-0) (Alonso  et al. 
2003). The data is available at the project web site (www.plantmetabolomics.org) as part of 
Experiment E1 (oxp1) and Experiment 3 (ggt1 and ggt2). Six mutant samples were compared 
with the two sets of wild type samples (six samples in each set) from the same experiment 
batch. The wild type sets from the same experiment batch were also compared with each other. 
All the metadata about the plant growth conditions, extraction protocols, mass spectrometry, 
instruments etc. is available for download at www.plantmetabolomics.org (Bais et al. 2010).The 
partial correlation analysis was done using 70 mutant lines along with the one wild type line from 
GC-TOF platform (Supplementary Document 5.2).  
Metabolite Detection platforms 
The Arabidopsis Metabolomics Consortium combined parallel analytical outputs from seven 
analytical platforms conducted on aliquots of the identical plant material to generate abundance 
data on 1042 peaks. Approximately 60% of this data was obtained from non-targeted GC-TOF-
MS and LC-MS platforms. The targeted analytical platforms were fatty acids, cuticular wax 
extraction, lipidomics, phytoesterols and isoprenoids extraction platforms. Currently 498 of the 
detected metabolite peaks are chemically defined by the analytical labs and 554 peaks have 
unknown structures. The complete data generation pipeline including each platform’s extraction 
and analytical protocol is available at www.plantmetabolomics.org (Bais et al. 2010).  Table 5.1 
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shows the number of metabolites detected by each platform along with the number of 
structurally known and unknown compounds. There was a six percent overlap of known 
metabolites between the platforms where the same metabolite was detected by more than one 
lab. 
 
Table 5-1  Platform Summary 
 
 
 
 
  
Platform 
Known 
Metabolites 
Unknown 
Metabolites Total Metabolites 
Fatty Acids (FA) 37 79 116 
Cuticle Wax (CW) 37 25 62 
Phytoesterols (PHY) 11 17 28 
Isoprenoids (ISO) 6 3 9 
Lipidomics (LPD) 171 0 171 
GC-TOF-MS (GC-TOF) 195 420 615 
LC-MS (LCMS) 41 0 41 
Total 498 554 1042 
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Metabolomics Analysis Pipeline 
The complete metabolomics analysis pipeline in Figure 5-1 is described in the following 
paragraphs. 
 
Figure 5-1 Data Analysis Pipeline 
Data Preprocessing 
 Repeatability analysis was performed within the six replicates of any single genotype samples 
(wild type or mutant) for each of the seven platforms separately using the non-parametric 
Spearman’s correlation (Spearman 1904)  on log (base 2) transformed data. This analysis 
showed more than 50% Spearman’s correlation coefficients between all pairs of replicates from 
a single genotype. For the ggt1/ggt2 study, phytoesterols data was completely discarded due to 
lack of repeatability. Please see supplementary document 5.1 for the detailed discussion on 
repeatability analysis.   
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Exploratory Data Analysis 
Log2 ratios of the average concentration of a metabolite from mutant samples and the average 
concentration from the wild type samples were calculated and plotted for all metabolites for 
each of the mutants. All the metabolomics platforms were combined together to generate a 
single ratio plot. Each point in the ratio plot showed the ratio of average abundance in mutant 
samples vs. the average abundance on the wild type samples for a metabolite on logarithmic 
scale. These plots visualize the overall trends in metabolite concentrations under the two 
genotypes by comparing the relative abundances of metabolites between mutant and the wild 
type samples on logarithmic scale and show which metabolites changed the most between the 
two types of samples. The points (metabolites) that were far from the central vertical axis had 
changed the most between the two conditions. The ratio plots were generated before any other 
normalization or scaling to see absolute changes in the metabolite levels. 
 
Figure 5-2  Log2 ratio plot between oxp1 mutant and wild type samples  
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 Data Preprocessing /Normalization 
A metabolite was discarded if it had more than 50% missing values otherwise the missing 
values were imputed by the average value of the metabolite abundance. Range scaling was 
used in normalizing the data to a range of minimum abundance value for a metabolite and 
maximum abundance value for the same metabolite across all the samples to give equal 
importance to high and low abundance metabolites and to remove the instrumental response 
factor from the data for the integration of the platforms (van den Berg et al. 2006, Smilde 
2005). 
Data Integration across multiple platforms 
Two methods for data integration were compared to find the optimal way to integrate the data 
from multiple platforms. In the batch integration method, all the metabolites from the seven 
platforms were concatenated side by side. All the metabolites were marked with the platform 
identification number to treat the common metabolites between two or more platforms as 
separate variables. In the hierarchical platform integration method, separate classifiers were 
built for each platform.  
Random Forest (RF) Analysis 
RF analysis  (Breiman 2001) has been shown as a suitable method for classifying high 
dimensional data when the number of features is much  higher than the number of samples 
(Lanz  et al. 2009) . Reproducibility and biological significance are the major goals of any 
biomarker analysis. In this study, we used the RF’s classification ability to determine if the 
mutant samples were metabolically different from the wild type samples using the .632+ 
bootstrap method (Efron et al. 1997). The .632+ bootstrap method is a widely used variation of 
the bootstrap resampling method and has been shown to perform well when the signal to noise 
ratio is small as in case of metabolomics data (Molinaro et al. 2005). In the basic bootstrap 
method, n samples are drawn with replacement for learning the model and the samples that are 
left out serve as the test set. The bootstrap estimate is the average error made on the left-out 
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samples. The basic bootstrap method tends to be high-biased because the number of samples 
in the learning set has .632n unique observations on average. The .632+ bootstrap method 
corrects for this by taking a weighted average of the bootstrap estimate.  
The stability of a metabolite to be selected as a biomarker in the original samples was evaluated 
by its frequency of getting selected in the 100 bootstrap runs. High frequency for a metabolite 
meant more stability of that metabolite as a biomarker. Margins were calculated by subtracting 
mean class membership probability for the wrong class from the mean class membership 
probability of the right class in the 100 bootstrap runs. Higher margins showed more confidence 
in the class membership.  The R package “randomForest” and “varSelRF” were used in the RF 
analysis (Liaw et al. 2002, Diaz-Uriate 2007).  
 Incorporating the structurally unknown compounds  
Structurally unknown metabolites comprise of about half of our data. Many of the key 
metabolites from RF analysis are also structurally unknown and do not provide any biological 
insight even when they are selected as potential biomarkers from a classification method (e.g. 
RF) described in the above paragraph. We harnessed our in-house data of 70 different mutant 
lines to build partial correlation networks among the metabolites in a separate global analysis. 
This analysis highlighted the strong correlations among the pair of metabolites that survived 70 
different mutations and   thus helped us in forming the hypothesis about the structurally 
unknown metabolites. Previous attempts on generating linear correlation networks based only 
on Pearson’s pairwise-correlation between the metabolites have not been very successful and 
do not match well with the actual known biochemical networks as they are unable to distinguish 
between direct and indirect reactions (Steuer et al. 2003a and 2003b, de la Fuente et al. 2004). 
Recent studies (Krumsiek et al. 2011) have suggested using partial correlation on the Pearson’s 
correlation matrix to remove the indirect relations between the metabolites. Using the simulated 
and actual human lipid metabolomics data, the authors have shown that the low order partial 
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correlation networks are very similar to the actual biochemical networks. However, even the low 
order partial correlation analysis requires large number of samples and small number of 
features. We addressed this problem by analyzing a small subset of structurally unknown 
metabolites that were  potential biomarkers  from RF analysis along with all known metabolites 
using the data from 70 different mutant lines (503 samples)(Supplementary document 8.5).  
First order GGMs were built using the pairwise Pearson correlation coefficients between two 
metabolites that were conditioned against the correlation with all other metabolites. Top pairwise 
correlations were chosen using a q value of 0.05. Once the correlation network was built, all the 
known metabolites that were directly connected by a single edge to an important unknown 
metabolite were highlighted. R package “GeneNet” (Schafer et al. 2005 a, 2005 b) and R 
package “igraph” (Csardi et al. 2006) were used in analyzing the graphs.  
The mass spectrum of the unknown metabolite was then analyzed using the BinBase library 
(Fiehn  et al. 2005) to find if the queried unknown compound’s mass spectrum closely matched 
with any known compounds. BinBase library shows 10 most similar mass spectrums to the 
queried compound using similarity criteria developed by Stein et al. (Stein et al. 1994). BinBase 
library comparison is available for the 75% of our unknown compounds from our database that 
are detected by the GC-TOF platform. This combined analysis gave more insight in 
hypothesizing biological role of unknown metabolites without more expensive structure 
determination methods.  
Results and Discussion 
The GSH degradation pathway was used to test the proposed methods for biomarker selection 
across platforms. In the first example, key biomarkers from the oxp1 mutant were found which 
agree with existing results and the identity and functions of some key unknown metabolites 
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were hypothesized. In the second example, the key biomarkers helped identify the effects of the 
two GGT mutants (ggt1 and ggt2).  
Figure 5.3 shows the GSH degradation pathway with literature verified parts as solid lines and 
hypothesized reactions as dashed lines. In mammals, the γ-glutamyl cycle functions to recycle 
the amino acids in extracellular glutathione (GSH) before they are lost to the animal’s excretory 
system. A sequence of reaction initiated by the extracellular γ-glutamyl transpeptidase (GGT) 
removes the glutamic acid (Glu) from GSH and thus initiates the import of the component amino 
acids back into the cell.  The removal of Glu from GSH can either be a hydrolysis reaction or a 
transferase where the Glu is transferred to an acceptor amino acid resulting in a γ-glutamyl 
amino acid dipeptide.  Both reactions are catalyzed by GGT (part 1A in pathway block diagram).  
Once the γ-glutamyl amino acid is returned to the cytosol it is converted to 5-OP and the free 
amino acid by the enzyme γ-glutamyl cyclotransferase (GGC) (part 1B).  Oxoprolinase (OXP1) 
catalyzes the ATP-dependent conversion of 5-OP to glutamic acid (part 1C) (Van der Werf et al. 
1971).The metabolism of GSH in plants is quite different.  Instead of a single GGT, Arabidopsis 
has three or four such proteins.  GGT1 and GGT2 are apoplastic with strong GGT1 expression 
throughout the plant and GGT2 predominately found in siliques (Ohkama-Ohtsu et al., 2007a).  
 In mammals, the extracellular GGT reactions appear to be the major route of GSH turnover. 
GGT1 knockout mutants in Arabidopsis show no change in GSH levels with respect to Wild 
Type, although the extracellular oxidized form of GSH (GSSG) levels are significantly elevated 
either causing or resulting from increased oxidative stress in this mutant in previous studies 
(Ohkama-Ohtsu et al., 2007b, 2008).  The major route of GSH turnover in Arabidopsis appears 
to be via a cytosolic γ-glutamyl cyclotransferase (part2B-i, part 2B-ii) (Ohkama-Ohtsu et al., 
2008).  Kinetic estimates suggest that about 90% of GSH in Arabidopsis is metabolized by this 
route. The product of the cyclotransferase reaction is 5-OP which is converted Glu by 5-
oxoprolinase (part 2C).  There is a single copy of the gene (OXP1) and the knockout mutant for 
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this gene (OXP1) appears to be unable to metabolize 5-OP which accumulates to high levels 
(Ohkama-Ohtsu et al., 2008). In this study, the known part (part 2C) of GSH pathway confirms 
the results of biomarker detection methods described in this study and the unknown part of the 
pathway (part 2A) is used in hypothesizing the functions of the GGT1 and GGT2 genes. 
 
Figure 5-3  GSH degradation Pathway 
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Metabolomics platform integration 
Table 5.2 compares the two data fusion strategies where samples from the oxp1 mutant were 
compared against the two sets of wild type samples and the wild type (WT) samples are 
compared against each other. The WT1 vs. WT2 comparison showed negative margins and 
high bootstrap prediction error rates using 100 samples. The metabolic profiles of the two wild 
type samples were expected to be similar and thus the negative margins and high error rate 
predictions were as expected. Both fusion strategies were able to select 5-OP as a potential 
biomarker in the oxp1mutation with more than 10% frequency in 100 bootstrap runs. This 
measure asses how often a given metabolite, selected when running the variable selection 
procedure in the original sample, is selected when running the procedure on bootstrap samples 
and thus provides a measure of stability of a potential biomarker. The hierarchical fusion 
method had an ensemble of seven models that were built for each platform separately. It 
showed low error rates and high margins for the GC-TOF and LC-MS platforms but high error 
rates and low margins for all the other platforms. The hierarchical method provided more 
biologically meaningful results than the batch integration method (Table 5.2, Table 5.3). The 
oxp1 mutation has been shown to work between 5-OP and glutamic acid in the literature 
(Ohkama-Ohtsu et al., 2008). The weak classifiers in fatty acids, cuticular wax, phytosterols, 
isoprenoids, and lipidomics platforms suggested that this mutation did not affect the metabolites 
detected by those platforms as they could not be used to differentiate between the mutants and 
wild type samples. The hierarchical fusion method was able to select glutamic acid as a 
potential biomarker in 15% of the bootstrap runs from the LC-MS platform. Although the 
classification accuracies for both the methods were at par for this mutant, the goal of a 
biomarker discovery is study  is  not only to classify the samples accurately but also select a 
small set of metabolites that can be repeatedly used in future studies when the class 
memberships are unknown. The hierarchical method also provides accuracy criteria for the 
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individual metabolomics detection platforms which can be used by the future studies to focus 
the attention on the platforms that provide strong models for a mutation under study. 
Table 5-2  Comparison of Platform integration methods – oxp1 vs. wild type 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
oxp1 Study 
 Low Level Fusion High Level Fusion 
 
oxp1-WT WT-WT oxp1-WT  WT-WT  
Bootstrap 
estimate of 
prediction error 
(100 Iterations) 
0.13 0.56 
0.49 (FA), 
0.42 (CW) 
0.49 (PHY) 
0.53 (ISO) 
0.48 (LPD) 
0.14 (GC-TOF) 
0.24 (LC-MS) 
0.63 (FA) 
0.62 (CW) 
0.35 (PHY) 
0.55 (ISO) 
0.59 (LPD) 
 0.53 (GC-TOF) 
 0.62 (LC-MS) 
Average Margin 
0.48 -0.15 
 -0.03 (FA) 
 0.13 (CW) 
 0.04 (PHY) 
-0.22 (ISO) 
-0.12 (LPD) 
 0.52 (GC-TOF) 
 0.27 (LC-MS) 
-0.31 (FA) 
-0.27 (CW) 
0.17 (PHY) 
-0.15 (ISO) 
-0.27 (LPD) 
-0.07 (GC-TOF) 
-0.31 (LC-MS) 
# Of metabolites 
952 (after missing 
values imputations) 
62(FA) ,62(CW),28(PHY) 
9(ISO),147(LPD),615(GC-TOF) 
29(LC-MS) 
 
# of metabolites 
with >10% 
frequency in 
100 bootstrap 
runs  
7 NA 
21  
(After removing 
weak models 
FA,ISO,PHY,LPD) NA 
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Table 5-3   Potential Biomarkers for oxp1 mutation 
# 
Metabolite U/D  
Frequency in 
100 Bootstrap 
Models 
Correlated 
Compound 
 
Similar Binbase Compounds 
(similarity score) 
HL LL 
  1 isothreonic acid  U 0.19 0.22 
  2 GABA D 0.18 0.17 
  
3 
213179 U 0.17 0.21 5-OP Glutamine,  N-acetyl-glutamic acid (*) 
4 succinic acid D 0.13 0.11 
  5 oxoproline U 0.11 0.11 
  
6 
303992 U 0.1 0.11 
5-OP, 
tocopherol Y , 
galactose 
Catechin (698.52) 
7 
200489 U 0.09 0.1 5-OP , homoglutamine  
N-acetyl-D-mannosamine 3 
(766.22), 
 galactitol (751.66),  
glucose 2 (746.55) 
8 melibiose U 0.08 0.05     
9 205672 D 0.07 0.06 mannonic acid NIST NA 
10 
alpha ketoglutaric 
acid D 0.07 0.04 
  11 4 hydroybutyric acid D 0.05 0.04     
12 glycerol D 0.05 0.02 
  13 serine D 0.05 0.02     
14 L Aspartic acid D 0.59 0.01     
15 GABA D 0.33 0.04     
16 L Isoleucine D 0.33 NA     
17 L Tryptophan D 0.26 NA     
18 L Citrulline D 0.17 NA     
19 L Glutamic Acid D 0.15 NA     
20 L Histidine D 0.12 0.01     
21 L Proline D 0.11 0.01     
22 L Threonine D 0.1 NA     
23 L Tyrosine D 0.09 NA     
24 L Phenylalanine D 0.06 NA     
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Incorporating the Unknown Metabolites 
An unknown metabolite with ID “213179” which is up regulated in oxp1 mutant samples appears 
with high frequency in the 100 bootstrap runs of RF classifiers in both methods. The partial 
correlation analysis shows that this metabolite is highly correlated with 5-OP across the 70 
mutation lines. Chromatogram analysis shows that this metabolite has high similarity with N-
acetyl-glutamic acid and glutamine. Our hypothesis about this metabolite is that it is a derivative 
of glutamic acid and is being up regulated in the mutant samples because 5-OP is not getting 
converted to glutamic acid due to the oxp1 mutation. 
Biological Confirmations and Discoveries 
oxp1 Mutant vs. Wild Type  
The potential biomarker list consists of up regulated  5-OP and down regulated glutamic acid 
along with many amino acids that are also down regulated. The results support the literature 
evidence that OXP1 works between 5-OP and glutamic acid. The oxp1 mutation down-regulates 
all the related amino acids as glutamic acid is a central molecule in amino acid metabolism in 
higher plants and  the α-amino group of glutamic acid is transferred to all other amino acids via 
assimilation and dissimilation of ammonia. Both the carbon skeleton and α-amino group are 
involved in the synthesis of γ-aminobutyric acid (GABA), arginine, and proline (Forde et al. 
2007). Sugars and the unknown metabolites putatively identified as sugars and flavonoid 
catechin  are up regulated in the mutant samples. The lack of differentiation in the models 
created from the targeted metabolomics platforms also showed that the oxp1 mutation may not 
affect lipids, fatty acid, cuticular wax, and isoprenoid or phytoesterol pathways.  
ggt1 Mutant vs. Wild Type  
The best classifier for this mutation was generated by the LC-MS platform in the hierarchical 
clustering method. The list of potential biomarkers consisted of many amino acids which were 
up regulated in the mutant samples (Table 5.4).  Notably, the potential biomarkers did not 
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include 5-OP. The results from this analysis confirm the hypothesis that GGT1 is not part of any 
major pathways for the 5-OP production and thus the ggt1 mutation should not affect 5-OP 
concentration (Ohkama-Ohtsu et al., 2008).  
Table 5-4   RF classification results for ggt1 mutant using two platform integration methods 
 
 
 
 
 
ggt1 Study 
 
Batch Integration Hierarchical Integration 
ggt1-WT WT-WT ggt1-WT  WT-WT  
Bootstrap estimate of 
prediction error (100 
Iterations) 
0.39 0.51 
0.45 (FA) 
0.45 (CW) 
0.41 (ISO) 
0.49 (LPD) 
0.41 (GC-TOF) 
0.17 (LC-MS) 
0.54 (FA) 
0.59 (CW) 
0.51 (ISO) 
0.46 (LPD) 
0.51 (GC-TOF) 
0.58 (LC-MS) 
Average Margin 
0.15 -0.07 
0.07 (FA) 
0.04 (CW) 
0.13 (ISO) 
-0.02 (LPD) 
0.11 (GCT-OF) 
0.46 (LC-MS) 
-0.14 (FA) 
-0.24 (CW) 
-0.06 (ISO) 
 0.08 (LPD) 
-0.01 (GCT-OF) 
-0.19 (LC-MS) 
# Of metabolites 1043 (959 after 
missing values 
imputations) 
91(FA) ,62(CW), 9(ISO),157(LPD),614(GC-TOF) 
32(LC-MS) 
 
# of metabolites with 
>10% frequency in 100 
bootstrap runs 
12 NA 24 NA 
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Table 5-5  Potential Biomarkers for ggt1 mutation 
 
 
 
 
 
 
 
 
 
 
ggt2 Mutant vs. Wild Type  
Both methods of data integration were unable to separate ggt2 and wild type samples as 
evident from the high prediction error rates and low margins from models built on all seven 
platforms (Table 5.6). The high error rate and low margins were at par when the two sets of wild 
type samples were compared with each other. This suggests that the ggt2 mutation may not 
have affected the biochemical profile of the cell, which supports the evidence that ggt2 has low 
expression levels in leaf tissues. Also, 5-OP was not significantly changed in this mutation as 
well, suggesting that GGT2 is also not involved in 5-OP production confirming the hypothesis 
from the previous studies (Ohkama-Ohtsu et al., 2008).  
 
 
 
 
Metabolite Name Up or Down? 
Frequency in 100 Bootstrap 
iterations 
   
Hierarchical 
Integration 
Batch 
integration 
1 L Proline U 0.73 0.21 
2 L Histidine U 0.7 0.14 
3 L Citrulline U 0.29 0.05 
4 L Asparagine U 0.28 #N/A 
5 
L alpha Amino n butyric 
acid U 0.23 0.06 
6 Beta Alanine U 0.2 #N/A 
7 L Glutamine U 0.13 #N/A 
8 delta Hydroxylysine U 0.09 #N/A 
9 L Homocystine D 0.08 #N/A 
10 Ethanolamine D 0.07 #N/A 
11 L Valine U 0.06 #N/A 
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Table 5-6  RF classification results for ggt2 mutant 
Conclusions 
This study shows that metabolomics platforms can be integrated effectively to form hypotheses 
about the functions of a gene. For example, in the oxp1 mutation study, both the reactant and 
the product of a hypothesized reaction (5-OP and glutamic acid) were detected by different 
metabolomics platforms (GC-TOF and LC-MS) to generate the biomarker profile of this 
mutation. The analysis confirms that OXP1 works between 5-OP and glutamic acid in the 
gamma-glutamyl pathway and may not affect pathways involving fatty acids, lipids, isoprenoids, 
sterols and cuticular waxes. Lack of any metabolic change in the ggt2 mutant samples supports 
the previous evidence that GGT2 may have low expression levels in the leaf tissues. We have 
explored a cost effective way of putatively identifying structurally unknown metabolites using 
partial correlation networks across many mutant lines.  
ggt2 Study 
 Batch Integration Hierarchical Integration 
 
ggt2-WT WT-WT ggt2-WT  WT-WT  
Bootstrap  estimate of 
prediction error (100 
Iterations) 
0.48 0.51 
0.49 (FA) 
0.45 (CW) 
0.46 (ISO) 
0.45 (LPD) 
0.46 (GC-TOF) 
0.51 (LCMS) 
0.55(FA) 
0.57 (CW) 
0.52 (ISO) 
0.43 (LPD) 
0.53 (GC-TOF) 
0.56 (LCMS) 
Average Margin -0.05 -0.02 
-0.03 (FA) 
0.05 (CW) 
0.03 (ISO) 
0.04 (LPD) 
-0.01 (GC-TOF) 
-0.05 (LCMS) 
-0.11 (FA) 
-0.21 (WT) 
-0.05 (ISO) 
-0.01 (LPD) 
-0.05 (GC-TOF) 
-0.18 (LCMS) 
# Of metabolites 
966 (after missing 
values imputations) 
95 (FA),  
 62 (CW) 
 9 (ISO) 
 153 (LPD) 
615 (GC-TOF) 
 32 (LCMS) 
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glutamate are both shortlisted as potential biomarkers using the hierarchical data integration 
method along with amino acids that are down regulated in the mutant samples. Glutamic 
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classification models in both data integration methods, suggesting that this mutation does 
not cause any biochemical changes in the cell and GGT2 may be a redundant gene. 
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CHAPTER 6. PARTIAL CORRELATION NETWORKS TO PUTATIVELY 
INDENTIFY UNKNOWN METABOLITES IN NON-TARGETED 
METABOLOMICS 
A paper to be submitted to Plant Methods 
Preeti Bais, Basil Nikolau, Julie A. Dickerson 
Abstract: 
About a third of the total number of the genes in Arabidopsis cannot be functionally annotated 
using sequence genomics techniques alone. Comparing the biochemical signature of samples 
from single gene knock outs with the wild type samples can provide clues to the functions of that 
gene. We individually compared 70  single gene knock outs of Arabidopsis mutants with wild 
type samples to find the potential biomarkers of each mutant.  The data was measured using 
non targeted gas chromatography mass spectrometry (GC-TOF) platform to get a global 
coverage of metabolite families. The Random Forest machine learning algorithm was used for 
classification of mutant samples from the wild type samples and selection of potential 
biomarkers for each mutant.   
Structurally unknown metabolites comprise of a big portion of any larger scale non-targeted 
metabolomics analysis. These metabolites do not provide any biological information unless the 
structures are determined using expensive and time consuming methods like tandem mass 
spectrometry or NMR. We propose a new method of computationally determining the putative 
identification of structurally unknown metabolites using partial correlation networks across many 
genetic strains. A researcher can use our biomarker database to find the potential biomarkers of 
a gene (mutant) of interest, get putative identifications of all unknown metabolites, visualize the 
impacted pathways and find other mutants that have similar biomarker profiles. They can also 
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use integrated data mining tools to see the mutant’s behavior using targeted platforms from our 
plantmetabolomics database for a more detailed analysis of the function of the gene along with 
the integrated morphological data to see the physical changes in plants and seeds.  
Introduction 
Metabolomics, which measures the concentration of small molecules (molecular weight < 1000 
Da) can be used in finding the functions of genes when sequence genomics techniques alone 
are not adequate. Non-targeted metabolomics analysis performs a global analysis of all the 
metabolites in an organism without any previous knowledge on the chemical and physical 
properties of the metabolites.  In a targeted metabolomics, small subset of known metabolites is 
enriched prior to the analysis increasing  the sensitivity of analysis. Since the non-targeted 
analysis is de novo in nature, there is large number of detected metabolites where chemical and 
physical properties cannot be determined without using more expensive and time consuming 
methods like NMR or tandem mass spectrometry. These metabolites cannot be used in finding 
the biological relevance of the factor under study without the structure determination. 
We propose a new method of putatively identifying the key unknown metabolites using partial 
correlation analysis across a large number of genetic strains. Unlike transcriptomic and 
proteomic correlation analysis, the observation of correlations in metabolites from the previous 
studies has not been able to identify known biochemical topologies using the standard 
correlation analysis with Pearson’s and Spearman’s correlations. Previous studies (Camacho et 
al. 2005, Steur R. 2006) have suggested various factors that contribute to the high correlations 
including (1) chemical equilibrium where metabolites reaching equilibrium show high positive 
correlations, (2) mass conservation – in a moiety conserved cycle at least one metabolite is 
negatively correlated to the rest of the group, (3) asymmetric control distribution – where 
intrinsic fluctuations a parameter that controls two metabolites causes high correlations among 
the metabolites (e.g. diurnal cycle) , and (4) unusually high variance in the expression of a 
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single gene. For example, a single enzyme that carries a high variance induces negative 
correlations between its substrate and product metabolites. A review by Steuer R. (Steuer R. 
2006) pointed out several issues with the previous correlation studies including the use a 
predefined correlation threshold and tendency of the nodes that have a common neighbor to be 
identified as connected in a Pearson’s correlation analysis. The author suggested using a partial 
correlation analysis on larger dataset across different genetic strains (or experimental 
conditions) to systematically identify the preserved correlations and thus detect the stable 
features or topologies of the underlying biochemical system. 
In a recent study on lipid metabolomics (Krumsiek J. et al. 2011), the authors have shown that 
partial correlation networks are similar to the actual biochemical while zero order person’s 
correlation networks are not. However, high order correlation networks have not been applied 
as often in metabolomics studies before because the number of features is much higher than 
the number of samples. In the present study, we took advantage of our in house data set which 
was generated using 194 structurally known metabolites across 503 samples. Using only the 
known metabolite, we generated first order correlation network algorithm GGM and show that 
the resulting networks are much sparser and match the actual biochemical pathways very well 
as the indirect correlations are removed. After showing that the highly correlated compounds 
from the partial correlation analysis are also neighbors in the actual biochemical networks, we 
use this strategy to find the neighbors of unknown metabolites .If those neighbor metabolites 
have known structures, we hypothesize that the unknown metabolite may belong to the same 
biochemical pathways as the known metabolites to have survived their correlations across so 
many mutations. This hypothesis can be verified with manually checking the raw 
chromatograms with our links to the GC-TOF library Binbase (Fiehn O. 2004). This method thus 
provides putative identifications of key unknown metabolites with the existing data and without 
the need for more expensive and time consuming methods.    
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Materials and methods 
Plant Materials  
Genetic parameters were manipulated by using Arabidopsis stocks that contained T-DNA 
insertions in a single gene and the environmental parameters were kept constant (Bais P. et al. 
2010). A total 0f 70 different gene mutants (six samples of each mutant) were compared with six 
different sets of wild type plants (with 6 samples in each set). The list of mutants is shown in 
table 6.1.  
Non targeted GC-TOF analysis  
The metabolites were detected using gas chromatography-mass spectrometry (GC-MS) 
platform and a total of 614 metabolites were detected for each genotype. 194 metabolites were 
structurally known and the rest were unknown metabolites. All the metadata about the Plant 
growth conditions, extraction protocols, mass spectrometry, instruments are available along with 
the data at the www.plantmetabolomics.org (Bais et al. 2010).  The total number of samples in 
the dataset was 503.    
Data Analysis 
Data Normalization 
 In a biological system, most of the metabolites are found in low abundance and only a small 
number of metabolites are in high abundance. Mean centering and range scaling methods were 
used to normalize metabolomics data. Range scaling uses biological range as the scaling factor 
(Dieterle et al. 2006, van den Berg et al. 2006).  
 
Random Forest Classification 
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Random Forest (RF) machine learning method  (Breiman 2001) has been used in 
transcriptomics and metabolomics studies for classification and biomarker discovery in recent 
years as it performs well when the number of samples are much lower than the number of 
features (Enot, 2006, Diaz-Uriate 2007). The selected features are not transformed as in PCA 
analysis and can be used directly in the biological interpretation and hypothesis generation. One 
of the main goals of a biomarker study is to find biomarkers that are not only able to separate 
the two classes of samples under study clearly but is  also reproducible. 25 bootstrap runs using 
.632+ bootstrap method (Efron B. et al. 1997) were used in classification procedure to generate 
reproducible results. A base line significance of the models was generated using six sets of wild 
type samples (with six replicates in each set) with each other and then comparing the wild type 
samples across the batches. Previous studies on RF (Enot D. et al. 2006) have suggested using 
class margins as criteria for accessing model quality along with the normally used classification 
accuracy measure. Bigger margins in class votes show high confidence in the votes for the right 
class and thus clear separation between the classes. Margins were calculated by subtracting 
the votes to the wrong class from the votes to the right class. 
Correlation Network Analysis 
Gaussian graphical models (GGMs), remove the indirect associations by conditioning the 
pairwise correlation among two variables on the correlations with all the other variables. A GGM 
is an undirected graph in which each edge represents the pairwise correlation between two 
variables conditioned against the correlations with all other variables. The GGM networks were 
constructed in a three step process by first constructing the Pearson’s correlation matrix, then 
calculating the partial correlations. Finally false discovery rate calculations were employed to 
remove the insignificant correlations. The metabolites were represented as vertices and the 
non-zero correlations between them were represented as edges in a graph. 
100 
 
R package “GeneNet” (Schafer et al. 2005 a, 2005 b) was used in analyzing the graphs in the 
GGM method. Top pairwise correlations were chosen using a q value of 0.05. The network 
analysis was performed using R package igraph (Csardi G. et al. 2006). 
 
 
Results and Discussion 
RF  classification and biomarker selection 
 
RF classification results of the same genotype (e.g. wild type VS. wild type model) had low 
average margins and high bootstrap (.632+) estimate of prediction error as expected because 
the metabolic signatures from the same genotype were expected to be very similar to each 
other under stable environment conditions. The error rate and average margins for the pairwise 
mutant vs. wild type RF classifications are shown in figure 6.1.  This figure helps in finding out 
which mutant cause more biochemical changes and which mutants cause insignificant changes. 
We have recently shown that ggt2 mutant may have low expression levels in leaf tissues and as 
shown in figure 6.1, this mutant’s classification with wild type samples is at par with wild type vs. 
wild type comparisons. Classification results from another mutant BCCP2 show high margins 
and low error rate in prediction and are investigated further.  
101 
 
 
Figure 6-1  RF  classification of 70 mutant lines of Arabidopsis with wild type samples 
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GGM Networks  
In the first round, GGM networks were built using the 194 known metabolites alone from the 70 
mutation lines using 503 samples to show that the correlation networks are similar to actual 
biochemical networks. The top 20 metabolite pairs with highest partial correlations are shown in 
table 6.1. Almost all the highest correlated metabolites are either from the same Aracyc pathway 
or share a common structure which can explain the high correlation coefficient between them. 
For example, mannonic acid NIST and gluconic acid which have similar structure in 
CHEBI database show a high correlation. Similarly, ornithine and N-acetylornithine which 
belong to the same Aracyc pathway “arginine biosynthesis II (acetyl cycle)” also show high 
correlation. 
In the second round of correlation analysis, top biomarkers with unknown structures from the RF 
study described above for the entire 70 mutant vs. wild type classification analyses were picked 
for further investigation. The unknown metabolites that appeared in at least 75% bootstrap runs 
for any of the 70 mutants were selected along with all the 194 known metabolites for the GGM 
analysis because the goal was to find a highly correlated known metabolite for a key unknown 
metabolite.  
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Table 6-1  Top 20 highly correlated compounds from GGM networks 
 
  
# Metabolite 1 Metabolite 2 pcor Comment 
1 GABA phosphoric acid -0.77 
 2 lignoceric acid palatinose 0.74 
 
3 
methionine 
sulfoxide xylonolactone 0.69 
 
4 ornithine N-acetylornithine 0.52 
arginine biosynthesis II 
(acetyl cycle) 
5 xylose arabitol 0.52 Sugar and Sugar Alcohol 
6 melibiose digalacturonic acid 0.51 Sugar and Sugar Acid 
7 malic acid 2-hydroxyglutaric acid 0.49 
 8 stearic acid heptadecanoic acid 0.46 Fatty acid family 
9 GABA oxoproline -0.44 γ-glutamyl cycle : 
10 octadecanol 1-hexadecanol 0.43 Both Alcohol 
11 ornithine citrulline 0.43 
arginine biosynthesis II 
(acetyl cycle) 
12 oxoproline phosphoric acid -0.42 γ-glutamyl cycle : 
13 mannonic acid NIST gluconic acid 0.41 Similar structure in CHEBI 
14 
phosphoethanolami
ne adipic acid -0.41 
 
15 glycine aminomalonic acid 0.40 
aminomalonic acid as an 
intermediate in the 
metabolic change of serine 
to glycine 
16 
phosphoethanolami
ne 3-ureidopropionate 0.39 
 17 pelargonic acid benzoic acid 0.39 Both are carboxylic acids 
18 cis-sinapinic acid cysteine-glycine 0.39 
http://www.ncbi.nlm.nih.gov
/pubmed/20188588 
19 GABA galactose -0.38 
glutamate degradation IV- 
Pyruvate-Glycolysis 
20 
conduritol-beta-
epoxide inositol allo- 0.38 
EC 3.2.1.21 - beta-
glucosidase bound as an 
ester of (+) chiro-inositol to 
aspartic acid 
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Table 6-2  RF classification results of SALK_070569 vs. wild type from 25 Bootstrap runs 
Potential 
Biomarker 
Frequency in 
bootstrap 
models 
Up or 
Down in 
Mutant? 
Top 3 Metabolites in 
partial correlation 
network 
Top 3 Similar 
compounds from 
Binbase database  
Other mutants 
with same 
biomarkers 
ribitol 0.84 
Up 
  
SALK_022584C 
SALK_022584C 
SALK_151779C 
SALK_126891C 
ELO 2/4 
SALK_040250 
SALK_062847C 
SALK_110264 
201060 0.28 
Up 
 
erythritol 
glycine 
ribitol 
threitol 
erythritol, ribitol,  
xylitol 563 
 
SALK_022584C 
SALK_022584C 
ELO 2/3/4 
SALK_151779C 
SALK_022971C 
SALK_075185 
ELO 2/3 
SALK_053394 
SALK_040250 
SALK_009522 
SALK_094382 
211896 0.24 
Up glucoheptulose 
 cellobiotol 
SALK_094382 
SALK_110264 
xylitol 0.12 Up   SALK_110264 
arabinose 0.08 
Up 
  
SALK_110264 
SALK_008656 
SALK_008505 
SALK_053394 
SALK_040250 
ornithine 0.08 
Up 
  
SALK_040250 
SALK_021437 
SALK_097354C 
ELO 2/4 
212373 0.08 
Up  
allantoin.5TMS 
arabitol 
cysteine 
octadecanol 
ribitol 
leucrose, 
glycerol-3-galactoside 
ELO 2/4 
SALK_040250 
228911 0.08 
Up arabitol 
N.acetyl.D.hexosamine 
ribonic.acid 
fructose 1 (sorbose 1) 
tagatose 1 
fructose 2 (sorbose 2) 
SALK_040250 
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Case Study and examples 
A mutant SALK_070569 (biotin carboxyl-carrier protein ,BCCP2, cac1b-2 allele) has been 
shown to have no perceptible effect on plant growth, development, and fatty acid accumulation 
using morphological data and reverse genetic approaches in a recent study (Xu L et al. 2011). 
Our analysis  for this mutant showed high class margins and low error rates as shown on top left 
portion of figure 6.1 (Point # 4). The potential biomarkers of this mutant did not contain any fatty 
acids or lipids confirming the literature evidence (Xu L et al. 2011). Table 6.2 shows the 
biomarker results for this mutant along with the top correlated compounds from the partial 
correlation analysis for the unknown metabolites.  The results from table 6.2 show that the 
alcohols or the unknown compounds that are highly correlated with alcohols may be potential 
biomarkers for this mutation. The chromatogram analysis from Binbase database provides 
further evidence that the unknown metabolites may be alcohols and not fatty acids. The partial 
correlation analysis provides putative identification for the unknown compounds which match 
the observations from Binbase database.  
The right most column of this table shows other mutants with similar potential biomarkers. An 
examination of the list shows that BCCP2 shares 4 biomarkers with mutant SALK_110264, 
which is  homomeric acetyl-CoA carboxylase gene (ACC2) as per the literature evidence 
(Babiychuk E. et al. 2011). This information is relevant because both the studies point out 
functional redundancy in malonyl-CoA biosynthesis with these two mutants which are also 
supported by our results. The bottom half of the page shows all the affected Aracyc pathways 
for BCCP2 and includes many amino acid biosynthesis pathways. 
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Conclusions 
We have created a database of metabolomics based potential biomarkers for 70 mutants in 
Arabidopsis that have not been annotated using sequence genomics techniques till date. We 
have also shown that the most correlated pairs of metabolites from the GGM analysis are either 
part of the same pathway or share structure similarity among each other and propose a new 
way to utilize this knowledge for annotating the unknown metabolites. A researcher can use the 
biomarker database to find the potential biomarkers for a gene of interest. They can then find 
putative identifications for the unknown metabolites in the biomarker list. All the other mutants 
that share those biomarkers are also made available along with the potentially impacted 
pathways that may be affected with the known metabolites and the using the putative 
identification of the unknown metabolites from the biomarkers list.  Combining these analyses 
will help the users in finding the biological impact of a mutation and thus lead to hypothesis 
generation about the function of a gene. The users can also use the integrated morphological 
database to see the morphological changes in the plants and use data mining tools at the 
integrated plantmetabolomics database ( www.plantmetabolomics.org) to analyze data from  
other targeted platforms like fatty acid, lipidomics, phytoesterols, isoprenoids , and cuticular wax 
from our consortium to further analyze the impact of the mutants. Detailed instructions and a 
case study with  step by step process on using this tool and database is provided at the 
supplimentary document 8.6. 
Availability of database 
The biomarker database is integrated with our existing plant metabolomics database at www. 
Plantmetabolomics.org. A user can search for a mutant (or gene) from the home page and then 
follow the easy directions to see the biomarker models for the give mutant. A detailed use case 
is also provided in the Appendix – Supplementary Documents 8.6. 
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CHAPTER 7. CONCLUSIONS 
We have shown that metabolomics can be a very effective functional genomics tool. The 
database contains metabolomics concentration and morphological data from 140 novel 
Arabidopsis mutant lines and 1400 metabolites. A researcher interested in any of these mutant 
lines or metabolites can easily use our web based tools to visualize and perform data mining 
and generate lists of biomarkers or find if two or more genes have similar metabolic profiles and 
thus form hypothesis about the functions of those genes. They can also investigate which family 
of metabolites are affected most or not affected at all due to a mutation and concentrate their 
future efforts accordingly.  
 One of the biggest challenges in any metabolomics experiments is to incorporate structurally  
unknown metabolites and it is often very expensive to find the structures of all the unknown 
metabolites using NMR and other techniques. In this thesis, we have presented a novel way to 
incorporate more information from the unknown metabolites by using novel computational 
methods on the existing data. These methods not only prioritize the unknown metabolites for the 
future structure determination studies but also provide more insight into their possible 
structures.   
We show that our methods not only confirm the known biology on GSH degradation pathway 
from Arabidopsis but this pathway in plants may be different than mammals which can be 
investigated further. Finally we present correlation networks of Arabidopsis that are built across 
70 different mutant lines and show stable relationships between the metabolites from non-
targeted GC-TOF platform. Many of the strong relationships from our analysis match very well 
with the known biochemistry and the some of the novel findings from our analysis can be 
investigated further to see if the strong relationships can guide us to novel pathways between 
those metabolites. 
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We have presented a web based relational database that can be easily adapted to mass 
spectrometry (MS) based plant metabolomics data from other plant species. 
In summary, we hope that this work can provide the research community with new tools to 
incorporate more knowledge from mass spectrometry based metabolomics and help establish 
metabolomics as a functional genomics tool. 
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CHAPTER 8. APPENDIX  – SUPPLEMENTARY DOCUMENTS 
Supplementary Document 8.1:  Data Quality analysis 
Replicate analysis for GC-TOF-MS Data for oxp1 Mutant 
This figure is used in replicate reliability analysis of an experiment. The bottom left corner of the 
figure shows the scatterplot matrix for different replicates. For an experiment with n replicates, n 
of these scatter plots will be drawn. Scatterplot on the ith row and the jth column corresponds to 
the replicates i and j. Each point in a scatterplot depicts a metabolite and its x and y coordinates 
are based on its concentration under two corresponding replicates. The experiments which have 
most of the points around the central diagonal in scatter plot are considered to be good because 
it shows that the experiment had similar results in all the runs. The numbers in the upper right 
corner show Spearman's correlation between two replicates. High numbers in this area indicate 
higher correlation between the replicates and thus high reliability between the replicates. The 
central figures show the distribution of metabolic concentrations in a replicate. Bell shaped 
figures depict that the metabolite concentrations are normally distributed and are considered to 
be good. 
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Figure 8-1 Replicate quality analysis   
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Table 8-1 Summary of Replicate quality analysis of platforms  
 
Analytical 
Platform 
Spearman's Correlation Range 
 oxp1 WT1 WT2 ggt1 ggt2 WT1 WT2 
Fatty Acids 
52 - 85 
57-91 23-85 71-90 69-91 58-87 53-
94 
Cuticle Wax 61-79 
56-86 57-85 41-90 72-88 62-89 52-
83 
Phytosterols 90-98* 
89-98* 70-98* 38-94** 23-99** 22-99** 87-
98** 
Isoprenoids 85-1.00 
71-97 95-100 95-100 93-100 95-100 97-
100 
Lipidomics 94-97 
93-98 93-98 98-99 96-98 98-99 97-
99 
GC-TOF-MS 85-91 
84-94 81-94 86-94 86-91 86-91 86-
93 
UPLC-Q-TOF 85-88 
85-89 84-88 87-91 84-88 87-90 86-
90 
 
Range of Spearman’s correlation between any two replicates of a single genotype for each 
analytical platform. Higher correlation number depicts high repeatability of experiments.  Since 
different sets of WT1 and WT2 samples were used for comparison with the ggt1 and ggt2 than 
for comparison with the oxp1 mutants, we have shown 4 different WT samples here. 
* Metabolite “BML-PS2-14.180-472.5” was removed before the analysis because it had two 
negative values. 
** 3 metabolites namely “BML-PS2-16.643-407.4”, “BML-PS2-14.180-472.5” and “phytol” from 
the Phytosterols platform were removed because some of the data contained negative values. 
 
Note: Phytosterol platform had some metabolites with negative abundance values because the 
intensity of a signature ion was lower in a sample than in the corresponding blank run and since 
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the platform protocol required  subtracting the background at any given retention time and any 
given signature ion from the corresponding value of the sample (Personal communication with 
Dr. B. Lange), this resulted in negative values. 
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Supplementary Document 8.2: List Of Genotypes used for Partial 
Correlation Analysis 
Table 8-2 List of Genotypes used for Partial correlation Analysis  
        # Name Genotype 
No. 
of 
Sam
ples 
# Name Genotype 
No. of 
Sample
s 
1 SALK_105337C  A1g71697 6 36 SALK_009731  At5g16370 6 
2 SALK_021437  At1g10670 6 37 SALK_074697  At5g19070 6 
3 SALK_011304C  At1g12880 6 38 SALK_078745  At5g37830 6 
4 SALK_137479C  At1g17160 6 39 SALK_112932  At5g37930 6 
5 SALK_072982  At1g34350 6 40 
SALK_130472
C  At5g38460 6 
6 SALK_110264  At1g36180 6 41 SALK_026454  At5g40010 6 
7 SALK_133954C  At1g49820 6 42 
SALK_093747
C  At5g43380 6 
8 SALK_013989  At1g50460 6 43 SALK_000892  At5g45300 6 
9 SALK_126003C  At1g60230 6 44 SALK_008505  At5g47720 6 
10 GABI_751B10  At1g65890 6 45 SALK_078710  At5g51420 6 
11 SALK_092412  At1g71890 6 46 
SALK_064795
C  At5g53580 6 
12 SALK_083029  At1g75000 6 47 
SALK_025686
C  At5g66550 6 
13 SALK_008656  At1g76130 5 48 
SAIL_690_G0
9 At1g03260 6 
14 SALK_044892  At2g01170 6 49 SALK_040250 At1g07990 6 
15 SALK_121515C  At2g03510 6 50 SALK_067448 At1g09430 6 
16 SALK_032878  At2g17650 6 51 
SALK_022584
C At1g22430 6 
17 SALK_143417C  At2g27490 6 52 
SALK_067463
C At1g35710 6 
18 SALK_090658C  At2g35020 6 53 
SALK_097354
C At1g58030 6 
19 SALK_022971C  At2g39670 6 54 SALK_009522 At1g75960 6 
20 SALK_063167  At2g42560 6 55 ELO 2/4 
At3g06470/At1g
75000 6 
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21 SALK_014489C  At2g46180 6 56 ELO 2/3/4 
At3g06470/At4g
36830/At1g750
00 
6 
22 SALK_109405  At3g06470 6 57 ELO 2/3 
At3g06470/At4g
36830 6 
23 SALK_003718  At3g16950 6 58 
SALK_062847
C At4g11100 6 
24 SALK_112040C  At3g19630 6 59 
SALK_016312
C At4g14930 6 
25 SALK_062081C  At3g49310 6 60 
SALK_024747
C At4g22890 6 
26 SALK_151779C  At3g52750 6 61 SALK_094382 At4g25000 6 
27 SALK_000817  At3g56130 6 62 ELO 3/4 
At4g36830/At1g
75000 6 
28 SALK_126891C  At4g08350 6 63 
SALK_130673
C At4g39520 6 
29 SALK_073183  At4g22880 6 64 SALK_137317 At5g01300 6 
30 SALK_092408  At4g29540 6 65 SALK_053394 At5g07990 6 
31 SALK_075185  At4g36830 6 66 SALK_020583 At5g13930 6 
32 SALK_004694  At4g39640 6 67 
SALK_114456
C At5g20080 6 
33 SAIL_6_G02  At4g39650 6 68 aae17/8 
At5g23050/At1g
55320 6 
34 SALK_090101C  At5g08120 6 69 
SALK_083600
C At5g61790 6 
35 SALK_070569  At5g15530 6 70 SALK_021108  At1g52670 36 
71 Wild type Col-0 54 
Total 240 Total 263 Grand Total  503 
  Grand Total  503 
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Supplementary Document 8.3: Applications of biomarker database and 
putative identification of unknown metabolites: Case Study 
 
Case study: Find the biomarkers of a mutation of interest 
Scenario: An investigator is interested in how the metabolome changes when comparing mutant 
and wild-type samples for a mutant of interest. Specifically, the investigator wants to know which 
metabolites show a significant change and which biochemical pathways they are involved in.  
The investigator is also interested in obtaining detailed information about specific metabolites 
from other web sources, other metabolites in the relevant biological pathways, and all the 
metadata associated with the selected mutant sample.  
For example, the investigator is interested in the metabolome changes for mutant 
“SALK_053394”, which has a T-DNA mutation in the Arabidopsis gene “At5g099970”.Below is a 
detailed description of a possible analysis path. Please note that analyses do not need to be 
done in this order.  Help icons are located throughout the database to aid users in 
understanding the tools available at PM.   
In the main web page, www.plantmetabolomics.org, the investigator selects the gene of interest 
from a drop down menu and clicks on  “Go” button. The resulting page shows a ratio plot of that 
mutant compared with all the wild type samples from the same experimental batch. The 
investigator can visualize which metabolites have more significant fold changes from the wild 
type. Metabolite names appear by moving the cursor over the plotted points. Missing or below 
detection limit values are depicted by different colored marks on the plot. After the exploratory 
analysis, the investigator can click on the “Biomarker DB” on top of the plot button to see 
potential biomarkers for this mutant which were generated using 25 bootstrap runs of random 
forest algorithm to compare wild type samples with the samples from the mutant of interest.  
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The resulting page shows the statistics of the analysis along with the other entire mutant vs. wild 
type comparisons in a clickable chart. High margins and low error rate depict that a mutant 
causes significant biochemical changes in the cell. The user is also provided a list of potential 
biomarkers for the queried mutant. The user can click on the metabolite name to see details of a 
metabolite (e.g. structure information, pathway information etc.). The third column on this table 
shows 3 highly correlated metabolites to each metabolite in the first column from the partial 
correlation analysis. For example the first potential biomarker for the given mutant is “201060” 
which is an unknown metabolite. The second column shows that it is highly correlated with 
ribitol. The second column links the metabolite to the Binbase database and shows the 
chromatogram of the queried metabolite along with 10 other metabolites whose chromatograms 
are similar to this compound. Some of the matching compounds include, “xylitol 563” and 
“ribitol”. The investigator can hypothesize that the unknown biomarker is a closely related 
compound to the alcohols from this analysis. The last column shows all the mutants in the 
database that share the biomarkers of the mutant of interest. This information can be used in 
finding if two mutants act in similar ways. Finally , the bottom portion of the page shows all the 
impacted Aracyc pathways with the mutation. All the known metabolites and putative 
identifications for the unknown metabolites are used in getting the pathways. 
The investigator can also use the integrated morphological images to see the physiological 
changes in the plant under the mutation and compare them with the images from the wild type 
samples. The integrated data mining tools can also be used at this time to analyze data from the 
integrated targeted platforms to get a more comprehensive view of the changes occurred due to 
the mutation. The combination of the results from this  database along with the 
plantmetabolomics database and data visualization tools will help in forming hypothesis about 
the functions of genes. 
